clarithromycin has been researched along with levofloxacin in 342 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (4.39) | 18.2507 |
| 2000's | 88 (25.73) | 29.6817 |
| 2010's | 157 (45.91) | 24.3611 |
| 2020's | 82 (23.98) | 2.80 |
| Authors | Studies |
|---|---|
| Hirayama, F; Ikeda, Y; Kawakita, T; Kuroda, T; Moriguchi, A; Sakurai, N; Sano, M; Uemori, S; Yamamoto, K | 1 |
| Keserü, GM | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Appelbaum, PC; Credito, KL; DeWasse, B; Kosowska-Shick, K; McGhee, P; Pankuch, GA | 1 |
| Ki, CS; Kim, IS; Kim, S; Lee, K; Lee, NY; Oh, WS; Peck, KR; Song, JH | 1 |
| Sasaki, T; Takahata, M; Yamazaki, T | 1 |
| Chang, CL; Jeong, J; Jeong, SH; Jung, HJ; Kim, HR; Kim, S; Lee, EY; Lee, JN; Shin, JH | 1 |
| Baba, S; Billal, DS; Fujihara, K; Hotomi, M; Nishimura, T; Suzuki, K; Yamanaka, N | 1 |
| Fukushima, K; Higashiyama, Y; Hirakata, Y; Kohno, S; Kohno, Y; Miyazaki, Y; Ohno, H; Yanagihara, K | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Appelbaum, PC; Clark, CL; Ednie, LM; Kosowska-Shick, K | 1 |
| Chiba, N; Hasegawa, K; Iwata, S; Matsubara, K; Morozumi, M; Nakayama, E; Sunakawa, K; Takayanagi, R; Ubukata, K | 1 |
| Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
| Fujimoto, K; Hirokawa, Y; Kashimoto, S; Kato, S; Kinoshita, H; Kitadai, N; Kojima, T; Nakata, K; Tanaka, T | 1 |
| Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Jia, L; Sun, H | 1 |
| Cao, R; Liu, J; Ma, C; Peng, W; Song, H; Wang, Z; Wu, Q | 1 |
| Esteban, J; Fernández-Martínez, AI; Fernández-Roblas, R; Gadea, I; García-Almeida, D; Martín-de-Hijas, NZ | 1 |
| Arakawa, Y; Kimura, K; Nagano, N; Nagano, Y; Tamai, K; Yanagisawa, H | 1 |
| Bohnert, JA; Fähnrich, E; Kern, WV; Schuster, S; Wehmeier, C | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
| Li, W; Liu, Y; Wang, M; Xu, X; Ye, X; Zhang, H; Zhu, D | 1 |
| Appelbaum, PC; Ednie, LM; Kosowska-Shick, K; McGhee, P | 1 |
| Iwata, S; Murayama, SY; Nakayama, E; Sakata, H; Seki, C; Sunakawa, K; Sunaoshi, K; Ubukata, K | 1 |
| Chen, H; Chen, M; Liu, Y; Ma, Y; Nichols, WW; Sun, W; Wang, H; Zhang, J; Zhao, C | 1 |
| Hamasuna, R; Jensen, JS; Osada, Y | 1 |
| Bae, S; Kang, Y; Kim, E; Lee, J; Lee, S; Yu, J | 1 |
| Appelbaum, PC; Beachel, L; Clark, C; Dewasse, B; Kosowska-Shick, KM; McGhee, P; Nagai, K | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Biedenbach, DJ; Castanheira, M; Jones, RN | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Baldelli, R; Cevenini, R; D'Antuono, A; Delucca, F; Di Francesco, A; Donati, M; Moroni, A; Shurdhi, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Inagaki, H; Kitamura, T; Komoriya, S; Kuroyanagi, J; Miyauchi, RN; Nagamochi, M; Odagiri, T; Sugimoto, Y; Takahashi, H | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Cheng, WC; Hsu, TL; Liou, JM; Tseng, YY; Wong, CH; Wu, MS | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Aldrich, C; Brody, S; Cushman, M; Fan, BZ; Hiasa, H; Liang, JH; Lv, W; Yang, ZY | 1 |
| Odagiri, S | 1 |
| Citron, DM; Claros, MC; Goldstein, EJ; Hunt Gerardo, S | 1 |
| Chimura, T | 2 |
| Akaki, T; Sato, K; Tomioka, H | 2 |
| Akaki, T; Kawahara, S; Sato, K; Shimizu, T; Tomioka, H | 1 |
| Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
| Chen, C; Danziger, LH; Martin, SJ; Pendland, SL; Schreckenberger, PC | 1 |
| Kahn, J; Mauriz, Y; Ogilvie, P; Thornsberry, C | 1 |
| Appelbaum, PC; Jacobs, MR; Lin, G; Spangler, SK | 1 |
| Appelbaum, PC; Clark, CL; Jacobs, MR | 1 |
| Appelbaum, PC; Hoellman, DB; Jacobs, MR; Lin, G | 1 |
| Anstey, RJ; Lasko, B; Lau, CY; Martel, A; Reddington, JL; Saint-Pierre, C | 1 |
| Akaki, T; Ogasawara, K; Sato, K; Tomioka, H | 1 |
| Hatakeyama, S; Oka, T; Suzuki, K; Tachibana, A; Tateda, K; Yamaguchi, K | 1 |
| Higashiyama, Y; Hirakata, Y; Kadota, J; Kaneko, Y; Kohno, S; Kuroki, M; Maesaki, S; Miyazaki, Y; Ohno, H; Sawai, T; Tashiro, T; Tomono, K; Yanagihara, K | 1 |
| Akaki, T; Kawahara, S; Sato, K; Tomioka, H | 1 |
| Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
| Enomoto, H; Hasegawa, A; Kawana, H; Kitada, M; Kuriyama, T; Nakamura, H; Ohmori, S; Ohtsuka, T | 1 |
| Hammerschlag, MR; Kutlin, A; Roblin, PM | 1 |
| Sano, C; Sano, K; Sato, K; Shimizu, T; Tomioka, H | 1 |
| Busman, TA; Dattani, D; Devcich, KJ; Gotfried, MH; Notario, GF; Palmer, RN; Riffer, E | 1 |
| Brade, V; Enzensberger, R; Gruschke, A | 1 |
| Weiss, LR | 1 |
| Cabré, X; Falguera, M; Ferrer, G; Pérez, J; Ruiz, A; Sacristán, O; Vallverdú, M | 1 |
| Katouno, Y; Kobayashi, Y; Sugita, K; Uchida, H | 1 |
| Malcolm, C; Marrie, TJ | 1 |
| Hata, K; Hisamori, S; Inoue, T; Ishimaru, H; Katoh, K; Maeda, Y; Maniwa, K; Minaguchi, M; Oida, K; Sakuramoto, M; Taguchi, Y; Tanaka, E; Terada, K | 1 |
| Itoh, Y; Kikuchi, K; Nakanishi, K; Nakao, S; Ohsaki, Y; Osanai, S; Saito, K; Sato, M; Tachibana, M; Takahashi, T; Toyoshima, E | 1 |
| Hasegawa, M; Kobayashi, I; Matsuzaki, K; Sato, Y; Shikano, M; Watabe, E; Yamanaka, N; Yoshimori, K | 1 |
| Aoyama, N; Fukuda, M; Kachi, M; Kasuga, M; Kuroda, K; Maekawa, S; Miki, I; Shirasaka, D; Tamura, T; Wambura, C; Watanabe, Y | 1 |
| Branca, G; Cammarota, G; Cannizzaro, O; Cesaro, P; Cianci, R; di Caro, S; Fedeli, P; Gasbarrini, G; Lecca, PG; Martino, A | 1 |
| Bormann, G; Marsch, WC | 1 |
| Bagnardi, V; Botteri, E; Carobbio, A; Corrao, G; Falcone, C; Leoni, O; Zambon, A | 1 |
| Branca, G; Cammarota, G; Fadda, G; Gasbarrini, A; Gasbarrini, GB; Schito, AM; Spanu, T | 1 |
| Accornero, L; Bilardi, C; Dulbecco, P; Iiritano, E; Mamone, M; Mansi, C; Parodi, A; Reglioni, S; Savarino, E; Savarino, V; Vigneri, S; Zentilin, P | 1 |
| Eller, J; Ioanas, M; Linnhoff, A; Lode, H | 1 |
| González-Granda, D; Labrador, T; Martínez, I; Nieto, A; Querol-Borrás, JM; Querol-Ribelles, JM; Tenías, JM | 1 |
| Armstrong, EP; Malone, DC; Ramachandran, S; Skrepnek, GH | 1 |
| Nakagawa, T; Ogawa, K; Taga, S; Tano, M | 1 |
| De Vecchi, E; Drago, L; Legnani, D; Nicola, L; Prenna, M; Ripa, S | 1 |
| Bhusal, Y; Shiohira, CM; Yamane, N | 1 |
| Antos, D; Bästlein, E; Bayerdörffer, E; Buchner, M; Haferland, C; Hänel, C; Lehn, N; Meier, E; Schneider-Brachert, W; Stolte, M; Trump, F | 1 |
| Díaz F, A; Pavié G, J; Prida C, JM; Saldías P, F | 1 |
| Benito, LM; Bermejo, F; Bory, F; Castro-Fernández, M; Cosme, A; Ducons, J; Fernández-Bermejo, M; Gisbert, JP; Lamas, E; López-Rivas, L; Olivares, D; Pabón, M; Pérez-Aisa, A | 1 |
| Blasi, F; Tarsia, P | 1 |
| Mikamo, H; Tamaya, T; Tanaka, K; Watanabe, K | 1 |
| Cammarota, G; Candelli, M; Cazzato, A; Finizio, R; Gabrielli, M; Gasbarrini, A; Gasbarrini, G; Lauritano, EC; Nista, EC; Ojetti, V; Santoro, M; Zocco, MA | 1 |
| Komori, K; Miyajima, K; Nakada, N; Suzuki, Y; Tanaka, H; Yamashita, N; Yasojima, M | 1 |
| Komori, K; Nakada, N; Suzuki, Y; Tanaka, H; Yasojima, M | 1 |
| Pistiolas, D; Robotis, J; Rokkas, T; Sechopoulos, P | 1 |
| Cammarota, G; Candelli, M; Cremonini, F; Finizio, R; Gasbarrini, A; Gasbarrini, G; Nista, EC; Ojetti, V; Spada, C; Zocco, MA | 1 |
| Eguchi, K; Fujikawa, K; Fukuda, T; Motomura, M; Ooe, N; Suenaga, A | 1 |
| Falguera, M; Giménez, A; Gómez-Arbonés, X; Porcel, JM; Ruiz-González, A; Sánchez, V; Soler-González, J | 1 |
| Hassan, C; Morini, S; Perna, F; Ricci, C; Saracino, I; Vaira, D; Zullo, A | 1 |
| Cannaviello, C; De Francesco, V; Efrati, C; Hassan, C; Ierardi, E; Maconi, G; Manes, G; Morini, S; Panella, C; Piglionica, D; Scaccianoce, G; Zullo, A | 1 |
| Chang, WL; Chen, WY; Cheng, HC; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Bozzi, R; Cozzolino, A; Di Girolamo, E; Morante, A; Pasquale, L; Rispo, A | 1 |
| Almela, P; Barrio, J; Benito, LM; Bermejo, F; Bory, F; Calvet, X; Carneros, JA; Castro-Fernández, M; Cosme, A; Fernández-Bermejo, M; Franco, A; García-Durán, F; Gisbert, JP; Khorrami, S; Lamas, E; Modolell, I; Niño, P; O'Callaghan, E; Ortiz, V; Ortuño, J; Pérez-Aisa, A; Ponce, J; Rodrigo, L; Sánchez-Pobre, P; Tomas, A; Valer, MP | 1 |
| Arguedas, A; Blumer, JL; Bradley, JS; Melkote, R; Noel, GJ; Sáez-Llorens, X | 1 |
| Gigliotti, F; Morini, S; Ricci, C; Vaira, D; Zullo, A | 1 |
| Chan, FK; Lee, CC; Lee, VW; Ling, TK | 1 |
| Baba, T; Endo, T; Hagiwara, E; Komatsu, S; Matsumoto, Y; Nishihira, R; Ogura, T; Sato, T; Sekine, A; Shinohara, T; Sogo, Y; Takahashi, H | 1 |
| Cozzolino, D; Iovene, MR; Nardone, G; Pilloni, AP; Rocco, A; Romano, M; Russo, MI; Salerno, R; Tufano, MA; Vaira, D | 1 |
| Hagymási, K; Tulassay, Z | 1 |
| Dubrovskaia, NV; Dvoretskiĭ, LI; Filimonova, OIu; Grudinina, SA; Iakovlev, SV; Sidorenko, SV | 1 |
| Coelho, L; Moretzsohn, L; Sanches, B; Vieira, G | 1 |
| Elias, N; Odeh, M; Sabetay, S; Sheikh-Ahmad, M; Slobodin, G; Weller, B; Zaygraikin, N | 1 |
| Gu, CP; Huang, LP; Zhuang, ML | 1 |
| de Boer, WA; Janssen, MJ; Schrauwen, RW | 1 |
| Chang, WL; Cheng, HC; Sheu, BS; Wu, JJ; Yang, HB; Yang, YJ | 1 |
| Barrio, J; Castro-Fernández, M; Cosme, A; Gisbert, JL; Gisbert, JP; Marcos, S; Moreno-Otero, R; Pérez-Aisa, A; Rodrigo, L | 1 |
| Allerheiligen, V; Cambau, E; Corbel, C; Coulon, C; Deforges, L; Delchier, JC; Lascols, C; Megraud, F; Soussy, CJ | 1 |
| But, D; Chan, CK; Chan, FS; Chan, P; Cheung, TK; Chu, KM; Gu, Q; Hsu, A; Hung, IF; Leung, S; Seto, WK; Tong, TS; Wong, BC; Wong, SY | 1 |
| Angelini, R; Pontone, P; Pontone, S; Standoli, M | 1 |
| Cristofari, F; De Francesco, V; Giorgio, F; Hassan, C; Ierardi, E; Panella, C; Perna, F; Vaira, D; Vannella, L; Zullo, A | 1 |
| Abadia, EG; Dueñas, C; Fernandez-Bermejo, M; Gisbert, JP; Gonzalez-Garcia, G; Hernandez-Alonso, M; Mateos-Rodriguez, JM; Molina-Infante, J; Perez-Gallardo, B; Vinagre, G | 1 |
| Levy, I; Samra, Z; Shmuely, H; Yahav, J; Zevit, N | 1 |
| Arnold, F; Griffin, AT; Peyrani, P; Wiemken, T | 1 |
| Hibi, T; Nishizawa, T; Suzuki, H | 1 |
| Chang, CY; Chen, CC; Chen, MJ; Cheng, TY; Lee, YC; Lin, JT; Liou, JM; Sheng, WH; Wang, HP; Wu, MS | 1 |
| D'Ercole, C; De Francesco, V; Hassan, C; Vaira, D; Zullo, A | 1 |
| Abdelfatah, M; Assem, M; El Azab, G; Rasheed, MA; Shastery, M | 1 |
| Huang, X; Li, Y; Shi, R; Yao, L; Zhang, G | 1 |
| Hsueh, PR; Lee, PI; Yang, JC | 1 |
| Chang, JJ; Chang, LC; Chen, LW; Chien, RN; Fang, KM | 1 |
| Araj, GF; Awar, GN; Baban, TA; Kanj, SS; Naba, MR; Tabbarah, ZA | 1 |
| Cuomo, A; Federico, A; Gravina, AG; Iovene, MR; Marmo, R; Miranda, A; Nardone, G; Rocco, A; Romano, M; Salerno, R; Sica, M; Tiso, A | 1 |
| Gu, WQ; Liang, X; Liu, WZ; Lu, H; Sun, QJ; Xiao, SD; Zheng, Q | 1 |
| Hagiwara, E; Komatsu, S; Ogura, T; Sawahata, M; Sekine, A; Takahashi, H; Tsuchiya, N | 1 |
| Chang, CY; Chang, SC; Chen, MJ; Chian, H; Hung, HW; Lee, YC; Lin, JT; Liou, JM; Sheng, WH; Wang, YC; Wu, MS | 1 |
| Gisbert, JP; Molina-Infante, J | 1 |
| De Francesco, V; Vaira, D; Zullo, A | 1 |
| Ishii, Y; Kimura, S; Sato, T; Tateda, K; Yamaguchi, K | 1 |
| Lochmannová, J | 1 |
| Baik, GH; Jung, HC; Kim, GH; Kim, HB; Kim, JM; Kim, JY; Kim, NY; Kim, SJ; Lee, DH; Nam, RH; Song, IS | 1 |
| Dan, M; Rosenberg, S; Samra, Z | 1 |
| Goh, KL; Navaratnam, P | 1 |
| Choi, KH; Chung, WC; Jung, SH; Kang, BK; Kim, EJ; Lee, KM; Oak, JH; Paik, CN | 1 |
| Budak, A; Karczewska, E; Sito, E; Wojtas-Bonior, I; Zwolińska-Wcisło, M | 1 |
| Basu, PP; Flynn, M; Krishnaswamy, N; Pacana, T; Rayapudi, K; Shah, NJ | 1 |
| Chuah, SK; Hsu, PI; Tsay, FW; Wu, DC | 1 |
| D'Arcy, S; Glocker, E; Lasseter, G; Lawson, AJ; McNulty, CA; Nichols, T; Shaw, I | 1 |
| Andersen, LP; Coenen, S; Glupczynski, Y; Goossens, H; Hirschl, AM; Kist, M; Lopez-Brea, M; Megraud, F; Versporten, A | 1 |
| Almela, P; Barrio, J; Bermejo, F; Bory, F; Calvet, X; Castro-Fernández, M; Cosme, A; Fernández-Bermejo, M; Franco, A; Gisbert, JP; Guerra, I; Khorrami, S; Lamas, E; Modolell, I; Ortuño, J; Pérez-Aisa, A; Ponce, J; Rodrigo, L; Sánchez-Pobre, P; Tomas, A | 1 |
| Aresti-Zárate, S; Ayestarán, B; Campos, MR; Carrascosa, MF; Cobo, M; Cuadrado-Lavín, A; Dierssen-Sotos, T; Fernández-Pousa, A; González-Colominas, E; Hernández, M; Pascual, EL; Salcines-Caviedes, JR | 1 |
| Kato, S; Kobashi, Y; Mouri, K; Obase, Y; Oka, M | 1 |
| Buzás, GM | 1 |
| Azzolini, F; Bedogni, G; Camellini, L; Cavina, M; Decembrino, F; Di Mario, F; Formisano, D; Iori, V; Sassatelli, R; Sereni, G; Tioli, C | 1 |
| Cerqueira, RM; Correia, MR; Fernandes, CD; Manso, MC; Vilar, H | 1 |
| Castelli, V; Fiorini, G; Gatta, L; Holton, J; Ricci, C; Ridola, L; Saracino, IM; Vaira, D; Zaccaro, C; Zullo, A | 1 |
| Breurec, S; Burucoa, C; Dia, D; Mbengue, M; Onambele, M; Raymond, J; Seck, A | 1 |
| Imai, Y; Inokuma, T; Matsumoto, T | 1 |
| Gisbert, JP; Marin, AC; McNicholl, AG | 1 |
| Barrio, J; Gisbert, JP; Marin, AC; McNicholl, AG; Molina-Infante, J; Vinagre, G | 1 |
| Aguirre, A; Albaiceta, GM; Amado-Rodríguez, L; Astudillo, A; Batalla-Solís, E; Blazquez-Prieto, J; García-Prieto, E; González-López, A; López-Alonso, I | 1 |
| Bonfrate, L; Castorani, L; D'Ambrosio, P; De Francesco, V; Hassan, C; Portincasa, P; Ruggiero, V; Scaccianoce, G; Vannella, L; Zullo, A | 1 |
| Denno, K; Horiki, M; Minoda, Y; Tada, K; Yano, K; Yoneda, M; Yoshida, T | 1 |
| Algaba, A; Antón, R; Barrio, J; Bermejo, F; Castro-Fernández, M; Cosme, A; Fernandez-Bermejo, M; Gisbert, JP; Gonzalez-Barcenas, M; Harb, Y; Marín, AC; McNicholl, AG; Modolell, I; Molina-Infante, J; Perez-Aisa, A; Rodrigo, L; Sacristán, B | 1 |
| Alvarez, B; Cruz, ME; Dib, J; Mendez, L | 1 |
| Alkhenizan, AH; Alsohaibani, FI; Peedikayil, MC | 1 |
| Almeida, N; Cardoso, O; Cipriano, MA; Donato, MM; Luxo, C; Marinho, C; Romãozinho, JM; Sofia, C | 1 |
| Koh, S; Maeda, N; Nishida, K | 1 |
| Gotoh, M; Katagiri, S; Nakamura, I; Ohyashiki, K; Yoshizawa, S | 1 |
| Fukushima, S; Ichihara, A; Ihn, H; Inoue, Y; Jinnin, M | 1 |
| Heo, J; Jeon, SW | 1 |
| Goodwin, JS; Kuo, YF; Lin, YL; Parekh, TM; Raji, M; Tan, A | 1 |
| Al-Hatmi, AS; Cilo, BD; Curfs-Breuker, I; Ener, B; Ersal, T; Meis, JF; Özkalemkaş, F; van Diepeningen, AD | 1 |
| Aisa, AP; Barrio, J; Castro-Fernández, M; Cosme, A; Fernández-Bermejo, M; Gisbert, JL; Gisbert, JP; Marcos, S; Marín, AC; McNicholl, AG; Modolell, I; Molina-Infante, J; Rodrigo, L | 1 |
| Malfertheiner, P; Selgrad, M | 1 |
| Chan, KA; Chang, CH; Chou, HW; Lai, CL; Lai, MS; Wang, JL | 1 |
| Ben-Zvi, H; Boltin, D; Dickman, R; Kamenetsky, Z; Niv, Y; Perets, TT; Samra, Z | 1 |
| Hong, SN; Kim, JJ; Lee, H; Lee, JH; Lee, YC; Min, BH; Rhee, PL | 1 |
| Cappuccinelli, P; Le, VA; Paglietti, B; Phan, TN; Rubino, S; Santona, A; Tran, TN; Tran, VH | 1 |
| Daikos, GL; Delladetsima, I; Goukos, D; Karamanolis, GP; Ladas, SD; Xouris, D | 1 |
| Akdogan, RA; Ayaz, T; Bedir, R; Rakici, H | 1 |
| Cao, B; Chen, R; Du, Y; Hu, B; Hu, Y; Liu, Y; Liu, Z; Su, D; Sun, H; Wang, H; Wang, Z; Xu, X; Zhang, F; Zhang, R; Zhao, C; Zhuo, C | 1 |
| Aihara, M; Ishii, N; Makigami, K; Nakanaga, K; Sugawara, M; Suzuki, K; Umebayashi, Y | 1 |
| Almeida, N; Calhau, C; Cardoso, O; Cipriano, MA; Donato, MM; Fernandes, A; Luxo, C; Marinho, C; Romãozinho, JM; Sofia, C | 1 |
| Akkan, T; Aktaş, B; Atbaşı, ST; Başyiğit, S; Nazlıgül, Y; Şimşek, G; Uzman, M; Yılmaz, B; Yüksel, O | 1 |
| Fujii, T; Ito, A; Nakaminami, H; Noguchi, N; Utsumi, K | 1 |
| Mahachai, V; Prapitpaiboon, H; Vilaichone, RK | 1 |
| Asano, F; Masuda, A; Matsumoto, S; Matsuno, Y; Murakami, A; Sobajima, T; Tsuzuku, A | 1 |
| Casado-Caballero, F; Fernández-Gutierrez, C; Fernández-Moreno, N; Fernández-Sánchez, F; Hervas-Molina, AJ; Montiel Quezel-Guerraz, N; Navarro-Jarabo, JM; Pallares-Manrique, H; Pérez-Aisa, A; Puente-Gutierrez, JJ; Rivas-Ruiz, F; Rodríguez-Ramos, C | 1 |
| Annibale, B; Calabrese, C; Caselli, M; Di Mario, F; Farinati, F; Gasbarrini, G; Gullini, S; Ierardi, E; Luzza, F; Maconi, G; Ojetti, V; Pretolani, S; Romano, M; Rugge, M; Savio, A; Stockbrugger, R; Zagari, RM | 1 |
| Guo, B; Li, BZ; Li, P; Mao, C; Threapleton, DE; Wang, JY; Xu, JM; Ye, DQ; Ye, QL; Yuan, JQ; Zhang, C | 1 |
| Boyanova, L; Evstatiev, I; Gergova, G; Mitov, I; Yaneva, P | 1 |
| Chiang, YS; Chien, CC; Chiou, SS; Chou, YP; Chuah, SK; Hu, ML; Hu, TH; Kuo, CH; Kuo, CM; Kuo, YH; Lee, CH; Liang, CM; Lu, LS; Tai, WC; Wu, IT; Yang, SC; Yen, YH | 1 |
| Boyanova, L; Evstatiev, I; Gergova, G; Kandilarov, N; Markovska, R; Mitov, I; Spassova, Z; Yaneva, P | 1 |
| Hashiguchi, N; Inoshima, I; Inoshima, N | 1 |
| Al Kaabi, S; Babu, R; Chandra, P; Derbala, M; Doiphode, S; John, A; Sharma, M; Yacoub, R | 1 |
| Cataldi, V; Cellini, L; Ciccaglione, AF; Di Bartolomeo, S; Di Campli, E; Di Giulio, M; Grossi, L; Marzio, L; Nostro, A | 1 |
| Aramin, H; Crowe, SE; Gupta, S; Park, JY; Thung, I; Valasek, MA; Vavinskaya, V | 1 |
| Chen, L; Chen, X; Jia, X; Li, N; Liu, W; Sun, H; Tong, H; Xiang, R; Xu, Y; Zhang, F; Zhang, J; Zhao, H | 1 |
| Bohnert, JA; Handzlik, J; Kaczor, A; Karcz, T; Kern, WV; Kieć-Kononowicz, K; Olejarz, A; Schuster, S | 1 |
| Bai, P; He, L; Song, Z; Xue, Y; Zhang, J; Zhou, L | 1 |
| Hwang, JC; Kang, JK; Kim, JH; Kim, SS; Lee, KM; Lim, SG; Park, RW; Shin, SJ; Yoon, D | 1 |
| Ji, C; Kong, C; Liu, G; Meng, X; Wu, J; Yang, L; Zhao, L; Zhu, X | 1 |
| Han, F; Ji, Z; Meng, F; Tu, M; Yang, N; Zhang, J | 1 |
| Dubini, M; Marraccini, P; Pignatti, P | 1 |
| Chiba, N; Fallone, CA; Fischbach, L; Gisbert, JP; Hunt, RH; Jones, NL; Leontiadis, GI; Marshall, JK; Moayyedi, P; Render, C; van Zanten, SV | 1 |
| Atzmüller, D; Betterklieber, C; Högenauer, C; Krause, R; Leitner, E; Mörth, E; Parsché, P; Pavek, J; Plieschnegger, W; Reicht, G; Reiter, L; Semlitsch, G; Stepan, V; Zollner-Schwetz, I | 1 |
| Kishimoto, K; Matsuse, H; Nakayama, H; Oshio, T | 1 |
| Alvaro, D; Bellesia, A; De Francesco, V; Hassan, C; Ridola, L; Vaira, D; Zullo, A | 1 |
| Campitelli, E; Catalano, M; Corti, R; Goldman, C; Ibarra, D; Mendiondo, N; Salim, N; Viola, L; Wonaga, A; Zerbetto De Palma, G | 1 |
| Miftahussurur, M; Sharma, RP; Shrestha, PK; Subsomwong, P; Yamaoka, Y | 1 |
| Han, JP; Hong, SJ; Ko, BM; Lee, JS; Lee, MS; Lee, TH; Lee, YN; Noh, HM; Park, KW | 1 |
| Adi, P; Akada, J; Akil, F; Maimunah, U; Makmun, D; Maulahela, H; Miftahussurur, M; Mustika, S; Nusi, IA; Rahardjo, D; Rezkitha, YA; Saudale, AM; Simanjuntak, D; Subsomwong, P; Suzuki, R; Syam, AF; Uwan, WB; Waleleng, JB; Waskito, LA; Wibawa, ID; Yamaoka, Y; Yusuf, F; Zein, LH | 1 |
| Chey, WD; Howden, CW; Leontiadis, GI; Moss, SF | 1 |
| Shokri-Shirvani, J; Zamani, M; Zamani, V | 1 |
| Chen, PY; Liou, JM; Wu, MS | 1 |
| Almeida, N; Branquinho, D; Cabral, JE; Casela, A; Donato, MM; Gregório, C; Tomé, L | 1 |
| Chen, H; Hao, B; Su, J; Zhang, G; Zhang, W; Zhou, X | 1 |
| Chang, WL; Chen, WY; Cheng, HC; Lin, CH; Lu, CC; Ou, HY; Sheu, BS; Wu, CT; Yang, HB; Yang, YJ | 1 |
| Gisbert, JP; Marin, AC; McNicholl, AG; Nyssen, OP | 1 |
| Bjornsson, ES; Gudjonsson, H; Gunnarsdottir, AI; Hardardottir, H; Jonsdottir, KD | 1 |
| Hu, Y; Lu, NH; Zhu, Y | 1 |
| Ang, D; Ang, TL; Chew, CA; Lye, TF | 1 |
| Alirezaei, A; Argani, H; Darvish, P; Iranshahi, M; Jamshidi Fard, A; Nooraninia, S; Talaie, R | 1 |
| Chowers, Y; Geffen, Y; Khoury, J; Saadi, T; Shaul, R; Sholy, H | 1 |
| Das, R; El-Omar, EM; Goh, KL; Kuo, YT; Leow, AHR; Lin, JT; Liou, JM; Lu, H; Tu, YK; Wu, JY; Wu, MS; Yamaoka, Y | 1 |
| Costa, S; Gonçalves, R; Soares, JB | 1 |
| Hardin, JW; Hyche, S; Magagnoli, J; Sutton, SS | 1 |
| Azrad, M; Brodsky, D; Isakovich, N; On, A; Pastukh, N; Peretz, A | 1 |
| Cerqueira, RM; Correia, M; Manso, MC; Vilar, H | 1 |
| Bellesia, A; De Francesco, V; Palma, R; Panetta, C; Pontone, S; Serviddio, G; Zullo, A | 1 |
| Chen, SY; Chen, Y; Chen, YX; Cheng, H; Du, YQ; Huo, LJ; Jiang, MD; Lan, CH; Li, Y; Liu, DS; Lu, H; Lu, NH; Shu, X; Wang, JB; Wang, YH; Wu, KC; Xie, Y; Xu, JM; Xu, SP; Zeng, ZR; Zhang, GX; Zhang, LX; Zhang, ZY; Zhu, X; Zhu, Y | 1 |
| Chen, Q; Li, H; Liang, X; Lu, H; Zhang, W | 1 |
| Furuta, T; Horio, Y; Ichikawa, H; Kagami, T; Kato, A; Ohashi, N; Sahara, S; Sakao, Y; Sugimoto, K; Sugimoto, M; Yasuda, H | 1 |
| Belsey, J; Fiorini, G; Gatta, L; Ricci, C; Saracino, IM; Scarpignato, C; Vaira, D | 1 |
| Chan, EW; Chen, L; Cheung, KS; Graham, DY; Leung, WK; Wong, AYS; Wong, ICK; Wong, IOL; Yeung, KF | 1 |
| Fiorini, G; Pavoni, M; Saracino, IM; Vaira, D; Zullo, A | 1 |
| Blümel, B; Glocker, EO; Goelz, H; Kist, M | 1 |
| An, Z; Bie, M; Huang, H; Tang, C; Wan, L; Wang, B; Zhou, Y | 1 |
| Bair, MJ; Chang, CC; Chang, CY; Chen, CC; Chen, MJ; Chen, PY; El-Omar, EM; Fang, YJ; Hsu, WF; Hsu, YC; Lee, JY; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Wu, MS; Yang, TH | 1 |
| Gastal, OL; Gonçalves, CV; Ramis, IB; Ramos, DF; Silva, PEAD; Silva, RAD; Vianna, JS | 1 |
| Barone, M; Di Leo, A; Giorgio, F; Girardi, B; Iannone, A; Ierardi, E; Palmer, SC; Pricci, M; Principi, M; Riezzo, G; Russo, F; Strippoli, GF | 1 |
| Gonçalves, JP; Lima, R; Nascimento, J; Pereira, F; Silva, GM; Silva, HM | 1 |
| Jones, L; Kelsburg, G; Safranek, S; Ta, J | 1 |
| Chen, PY; Kuo, YT; Liou, JM; Wu, MS | 1 |
| Akther, N; Amjad, T; Amjed, S; Ashraf, N; Jafar, J; Latif, S; Maqsood, W; Saleem, B; Usman, M; Waseem, H | 1 |
| Alimov, A; Dekhnich, N; Ivanchik, N; Kirsov, P; Kozlov, R; Pandav, K; Steshits, A | 1 |
| Shahbazi, S; Vahdat Shariatpanahi, Z | 1 |
| Baylina, M; Calvet, X; López-Góngora, S; Muñoz, N; Puig, I; Sánchez-Delgado, J | 1 |
| Fallone, CA; Malfertheiner, P; Moss, SF | 1 |
| Chen, Q; Chen, Y; Gao, H; Graham, DY; Ji, Y; Li, D; Liang, X; Liu, M; Liu, W; Long, X; Lu, H; Song, Y; Sun, Y; Xu, B; Xu, G; Yu, L; Zhang, W; Zhao, Y | 1 |
| Ahn, JY; Baik, GH; Cheung, DY; Cho, SJ; Choi, KD; Choi, YJ; Chung, JW; Jung, HK; Jung, HY; Kim, BW; Kim, JH; Kim, JJ; Kim, JM; Kim, SY; Lee, H; Lee, JH; Lee, SH; Lee, WS; Min, YW; Park, JC; Shin, CM; Sung, JK | 1 |
| Hanafy, AS; Seleem, WM | 1 |
| Edler, KJ; Oliveira, ON; Ortiz-Collazos, S; Picciani, PHS; Pimentel, AS | 1 |
| Bluemel, B; Eisele, B; Glocker, EO; Goelz, H; Goldmann, B; Grüger, J; Hamel, H; Hofreuter, D; Loley, K; Ludolph, T; Meyer, J; Miehlke, S; Mohr, A; Tüffers, K; Usadel, H; Vorreiter, J; Wagner, S; Wenzel, H; Wiemer, L | 1 |
| Álvarez-Argüelles, ME; Armesto, E; Duque, JM; Melón, S; Morilla, AM; Villar, H | 1 |
| In Choi, S; Kim, N; Lee, DH; Lee, JW; Lee, JY; Nam, RH | 1 |
| Arévalo, A; Otero, WA; Trespalacios, AA | 1 |
| Noguchi, N; Saito, M; Seyama, S; Tanaka, E; Wajima, T; Yamada, S; Yuzawa, Y | 1 |
| Ang, D; Ang, TL | 1 |
| Jin, Z; Li, Y; Lin, D; Lin, L; Meng, F; Pan, J; Shi, Z; Wu, J; Yang, N; Zhang, J; Zhou, Q | 1 |
| Chu, A; Gong, Y; Guo, Q; Lv, Z; Wang, D; Yuan, Y | 1 |
| Bie, S; Botchway, BOA; Chen, B; Fang, M; Gu, H; Jiang, M; Li, F; Peng, K; Shu, X; Yin, G; Zhao, H; Zheng, W | 1 |
| Cogdill, AG; Guevara, B | 1 |
| Alcaide, N; Areia, M; Ariño, I; Axon, T; Barrio, J; Bordin, D; Boyanova, L; Brglez Jurecic, N; Bujanda, L; Buzas, G; Bytzer, P; Caldas, M; Capelle, L; Castro-Fernández, M; Dominguez-Cajal, M; Garre, A; Gasbarrini, A; Gisbert, JP; Goldis, A; Huguet, JM; Jonaitis, L; Kunovský, L; Kupcinskas, L; Lamy, V; Leja, M; Lerang, F; Lucendo, A; Marcos Pinto, R; María Botargues Bote, J; Mégraud, F; Milosavljevic, T; Modolell, I; Niv, Y; Nyssen, OP; O'Morain, C; Ortuño, J; Pérez Lasala, J; Pérez-Aisa, Á; Perona, M; Phull, P; Przytulski, K; Rodrigo-Sáez, L; Rokkas, T; Romero, PM; Shvets, O; Simsek, I; Tepes, B; Tonkic, A; Venerito, M; Voynovan, I | 1 |
| Florez Bracho, L; Lasa, JS; Paz, S; Zubiaurre, I | 1 |
| Alshareef, A; Bach Dat, B; Duc, NT; Nam, NH; Ngoc, NM; Nguyen, JG; Reda, A; Thieu, H; Tien Huy, N | 1 |
| Aumpan, N; Mahachai, V; Ratanachu-Ek, T; Tshering, L; Uchida, T; Vilaichone, RK; Yamaoka, Y | 1 |
| Dang, NQH; Ha, TMT; Le, NDK; Nguyen, ST; Nguyen, TH; Nguyen, TMT; Pham, TTH; Tran, VH | 1 |
| Bazzoli, F; Frazzoni, L; Fuccio, L; Marasco, G; Zagari, RM | 1 |
| Hu, JN; Ji, CR; Ji, R; Li, LX; Li, YQ; Li, YY; Lin, MJ; Liu, J; Qiao, C; Qu, JY; Zuo, XL | 1 |
| Chang, YL; Hsu, PI; Kim, SE; Liou, WS; Shiu, SI; Tu, YK; Tung, YC; Wu, MF; Yang, JC; Yeh, HZ | 1 |
| Behrendt, J; Bluemel, B; Eisele, B; Franz, A; Glocker, EO; Hofreuter, D; Jansen, A; Koken, M; Meyer, J | 1 |
| Brglez Jurecic, N; Espada Sanchez, M; Gisbert, J; Mégraud, F; O'Morain, C; Perez Nyssen, O; Tepes, B; Tepes, K | 1 |
| Andreev, DN; Dzhedzheia, LV; Fomenko, AK; Govorun, VM; Ilina, EN; Kirillova, NV; Kriukov, KA; Kucheryavyy, YA; Lobanova, EG; Maev, IV; Maevskaya, EA; Melnikova, EV; Oganesian, TS; Parfenova, TV; Zaborovskii, AV; Zayratyants, OV | 1 |
| Arj, A; Gilassi, H; Madani, M; Razavizadeh, M | 1 |
| Bodmer, T; Egli, K; Keller, PM; Risch, L; Risch, M; Wagner, K | 1 |
| Alliet, G; Baert, F; Haems, L; Hervent, AS; Lambrecht, G; Vanden Bulcke, A; Vervaeke, S; Waked, B | 1 |
| Arenas, A; Arnold, J; Berger, Z; Camargo, MC; Castro, VG; Fuentes-López, E; González-Hormazábal, P; Jara, L; Lanzarini, E; Musleh, M; Pizarro, M; Riquelme, A; Serrano, C; Valladares, H | 1 |
| Abay, S; Akar, M; Aydın, F; Karakaya, E; Kayman, T | 1 |
| Andreev, DN; Kucheryavyy, YA; Maev, IV | 1 |
| Lehours, P; Mégraud, F | 1 |
| Imuta, N; Iuchi, H; Kiyama, S; Kurono, Y; Nishi, J; Ohori, J; Yamashita, M | 1 |
| Akpınar, H; Ellidokuz, H; Gökçekuyu, BM; Şimşek, İ; Soytürk, M; Yılmaz, Ö | 1 |
| Buset, M; De Wit, S; Delforge, M; Gomez-Galdon, M; Miendje-Deyi, VY; Muls, V; Nkuize, M; Vanderpas, J | 1 |
| Bang, MTL; Duc, NM; Khoi, HH; Nghi, BTD; Ngoc, TLC; Tien, VNT; Van Bach, N; Van Thieu, H | 1 |
| Chen, Q; Chen, Y; Huang, X; Ji, X; Lin, Z; Liu, Y; Lu, Y; Nong, G; Suo, B; Wei, J; Wu, B; Zhou, X | 1 |
| Akkus, S; Bahar-Tokman, H; Bal, K; Demirci, M; Demiryas, S; Ergin, S; Erzin, Y; Gareayaghi, N; Kocazeybek, B; Ozbey, D; Saribas, S; Tasci, I; Tufan-Kocak, B; Yuksel-Mayda, P; Ziver-Sarp, T | 1 |
| Askari, P; Ghazvini, K; Karbalaei, M; Keikha, M | 1 |
| Hu, M; Pang, X; Wang, L; Zhang, J | 1 |
| Li, Y; Luan, Z; Ma, C; Shi, C; Yang, L; Zhang, W; Zhao, Y | 1 |
| Areia, M; Barrio, J; Beglinger, C; Bordin, D; Boyanova, L; Bujanda, L; Buzas, GM; Bytzer, P; Caldas, M; Capelle, L; Castro-Fernandez, M; Doulberis, M; Fernandez-Salazar, L; Gasbarrini, A; Gisbert, JP; Goldis, A; Huguet, JM; Jonaitis, L; Jurecic, NB; Kunovský, L; Kupčinskas, J; Lamy, V; Lanas, A; Lasala, JP; Leja, M; Lerang, F; Lucendo, AJ; Marcos-Pinto, R; Marlicz, W; Megraud, F; Milivojevic, V; Molina-Infante, J; Morain, CO; Niv, Y; Nyssen, OP; Ortuño, J; Pérez Aísa, Á; Phull, P; Puig, I; Rodrigo, L; Rokkas, T; Sarsenbaeva, AS; Shvets, O; Simsek, I; Smith, S; Tepes, B; Tonkić, A; Vaira, D; Venerito, M; Vologzhanina, L; Voynovan, I | 1 |
| Adamski, R; Dworniczek, E; Krzyżek, P; Spiegel, M; Sroka, Z | 1 |
| Dore, MP; Graham, DY; Lee, YC | 1 |
| Continisio, A; D'Abramo, FS; Di Leo, A; Ierardi, E; Losurdo, G; Piazzolla, M; Pricci, M; Rima, R | 1 |
| Gościniak, G; Grande, R; Krzyżek, P; Migdał, P | 1 |
| Florholmen, JR; Goll, R; Halvorsen, FA; Johnsen, KM; Melby, KK; Moayeri, B; Nestegard, O; Paulssen, E; Sørbye, SW; Tønnesen, T | 1 |
| An, Z; Kang, L; Li, J; Ru, C; Tian, L; Wang, L; Yao, Y; Yin, L | 1 |
| Geng, T; Li, ZY; Liu, B; Yu, ZS; Zhang, HH; Zhou, XX | 1 |
| de Boer, MGJ; Kuijper, EJ; Molendijk, I; Schoffelen, AF; van den Brink, G; Veenendaal, RA; Woudt, SHS | 1 |
| Elfanagely, Y; Ho, JJC; Moss, SF; Navarro, M; Sawyer, K | 1 |
| Bai, F; Bo, Y; Chen, X; Deng, Y; Hao, Q; Hu, S; Li, X; Liu, J; Sang, T; Tang, Y; Wang, J; Zhong, Z; Zhou, Y | 1 |
| Karbalaei, M; Keikha, M; Talebi Bezmin Abadi, A | 1 |
| Buran, T; Gazi, H; Kurutepe, S; Sürücüoğlu, S | 1 |
| Lin, Y; Miao, M; Shao, Y; Wang, B; Ye, G | 1 |
| Benghezal, M; Li, H; Marshall, BJ; Shen, Y; Song, X; Tang, H; Tang, X; Wang, Z | 1 |
| Agay-Shay, K; Azrad, M; On, A; Paritski, M; Peretz, A; Rohana, H; Roshrosh, H; Vazana, D | 1 |
| Chan, MTV; Chen, H; Liu, X; Wu, WKK; Xie, C; Zeng, J; Zhang, L | 1 |
| Crumrine, M; Hewitt, JA; Slay, RM | 1 |
| Hu, C; Jiang, M; Li, H; Peng, K; Shu, X; Ye, D; Zhao, H | 1 |
| Fan, J; Han, Y; Liu, J; Meng, F; Sun, BB; Tao, H; Wang, G; Zhou, Y | 1 |
| Bontems, P; Burette, A; Delhaye, M; Gossum, MV; Kahegeshe, NL; Kotilea, K; Louis, H; Miendje Deyi, VY; Nkuize, M; Ntounda, R | 1 |
| Li, H; Shen, Y; Song, X; Tang, H; Zhou, J; Zhou, L | 1 |
| Choi, SI; Jang, JY; Kim, N; Lee, DH; Lee, JW; Nam, RH; Song, CH | 1 |
| Bair, MJ; Chang, CY; Chen, CC; Chen, CY; Chen, MJ; Chen, PY; Chiu, MC; Chou, CK; El-Omar, EM; Fang, YJ; Hsu, YC; Hu, WH; Jiang, XT; Kuo, CC; Lee, JY; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Tsai, MH; Tseng, CH; Wu, MS; Yang, TH; Yu, CC | 1 |
| Boyanova, L; Gergova, G; Gergova, R; Kandilarov, N; Markovska, R; Yordanov, D | 1 |
| Niu, Z; Ren, X; Song, Z; Suo, B; Tian, X; Xue, Y; Zhou, L | 1 |
| Ellakany, WI; Ghazy, RM; Ismail, A; Kamal, A; Sherief, D | 1 |
| Ayaş, M; Gürol, Y | 1 |
| Akyön, Y; Örsten, S; Yılmaz, E | 1 |
| Chen, C; Cheung, KS; Deng, Z; Leung, WK; Lyu, T; Ni, L; Seto, WK; Wu, J | 1 |
| Bo, Y; Cao, Y; Cao, Z; Chen, X; Cui, T; Deng, Y; Fu, L; Gao, H; Gao, R; Guo, J; Hao, Q; Hou, Z; Hu, J; Hu, S; Jin, L; Li, F; Li, H; Li, X; Li, Y; Liu, J; Ma, B; Ma, L; Ma, S; Ma, Z; Mu, R; Niu, M; Qi, H; Shi, R; Su, X; Tang, N; Tang, Y; Wang, P; Wang, X; Xin, R; Yang, B; Yang, W; Yao, L; Yong, H; You, Y; Yu, X; Yu, Y; Zhang, X; Zhao, W; Zhou, Y | 1 |
| Chua, EG; Gao, X; Han, X; Lai, B; Marshall, BJ; Tay, CY; Wang, X; Wei, X; Yu, X; Zhang, X | 1 |
| Ai, Q; Chen, Y; Hu, L; Li, GQ; Liu, C; Liu, L; Zeng, X; Zhang, X | 1 |
| Chasqueira, MJ; Cruz, C; Fernandes, F; Paixão, P; Rodrigues, L; Santos, R | 1 |
| Bair, MJ; Chen, CC; Chen, CY; Chen, MJ; Chen, PY; Chiu, MC; Chou, CK; El-Omar, EM; Fang, YJ; Hsu, YC; Hu, WH; Kuo, CC; Lee, JY; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Tsai, MH; Wu, MS; Yang, TH; Yu, CC | 1 |
| Chen, M; Dong, Y; Gong, Y; Li, Y; Sun, J; Wang, Y | 1 |
| Chen, J; Du, J; Fu, K; Jin, C; Mei, T; Pang, T; Qian, Q; Wang, Y; Wang, Z; Zhang, D | 1 |
| Feng, Q; Lang, C; Liu, L; Lu, K; Mu, Y; Sang, W; Xu, C; Zang, L; Zhao, J; Zou, X | 1 |
| Bontems, P; Iliadis, E; Kotilea, K; Mahler, T; Miendje Deyi, VY; Nguyen, J; Salame, A | 1 |
| Bujanda, L; Cilla, G; Gómez-Ruiz de Arbulo, M; Mendibil, L; Mendiola, J; Montes, M; Tamayo, E | 1 |
| Chen, Q; Chen, Y; Huang, X; Ji, X; Lin, Z; Suo, B; Wu, B; Zheng, X; Zhou, X | 1 |
| Bontems, P; Che, TH; Le, GKN; Nguyen, HT; Nguyen, LTH; Nguyen, PNV; Nguyen, TC; Pham, BV; Pham, DTH; Robert, A; Truong, DQ | 1 |
| Abay, S; Akar, M; Anuk, T; Aydin, F; Buyuk, F; Celebi, O; Karakaya, E; Kayman, T; Otlu, S; Ozcan, HE; Saticioglu, IB; Tarhane, S | 1 |
| Bryant, RV; Costello, SP; Ingram, PR; Rayner, CK; Roberts-Thomson, IC; Schubert, JP; Warner, MS | 1 |
| Dadić, B; Dželalija, M; Kalinić, H; Maravić, A; Šamanić, I; Sanader Maršić, Ž; Šundov, Ž; Tonkić, A; Tonkić, M; Vrebalov Cindro, P; Vuković, J | 1 |
| Atherton, J; Bakshi, N; Garvey, E; Letley, D; Mahmood, F; Rhead, J; Robinson, K; Suffian, S; Whiley, D; White, J; Winter, JA | 1 |
| Aumpan, N; Graham, D; Issariyakulkarn, N; Mahachai, V; Vilaichone, RK; Yamaoka, Y | 1 |
36 review(s) available for clarithromycin and levofloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Value of short-course antimicrobial therapy in community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Microspheres; Ofloxacin; Pneumonia; Time Factors; Treatment Outcome | 2005 |
[Treatment for Helicobacter pylori: current criteria].
Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Metronidazole; Ofloxacin; Practice Guidelines as Topic; Proton Pump Inhibitors; Quinolones; Tinidazole; Treatment Outcome | 2007 |
[The new aspects of the eradication of Helicobacter pylori and the importance of bacterial resistance].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Patient Compliance; Proton Pump Inhibitors; Risk Factors; Salvage Therapy; Treatment Failure | 2008 |
Helicobacter pylori eradication therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Ranitidine; Tetracycline; Treatment Failure; Treatment Outcome | 2010 |
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis.
Topics: Anti-Infective Agents; Aza Compounds; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Proton Pump Inhibitors; Quinolines; Randomized Controlled Trials as Topic; Recurrence; Retreatment | 2010 |
[Pulmonary mycobacteriosis caused by Mycobacterium peregrinum in a young, healthy man].
Topics: Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Levofloxacin; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2010 |
[Current perspective of the resistance of Helicobacter pylori strains to antimicrobial drugs].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors | 2010 |
A new look at anti-Helicobacter pylori therapy.
Topics: Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Tetracycline | 2011 |
[Helicobacter pylori - 2012].
Topics: Algorithms; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Emigrants and Immigrants; Endoscopy, Gastrointestinal; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Hungary; In Situ Hybridization, Fluorescence; Levofloxacin; Ofloxacin; Peptic Ulcer; Polymerase Chain Reaction; Stomach Neoplasms | 2012 |
A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication).
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Treatment Failure | 2013 |
Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2014 |
Optimal treatment strategy for Helicobacter pylori: era of antibiotic resistance.
Topics: Amoxicillin; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Polymerase Chain Reaction; Proton Pump Inhibitors; Treatment Outcome | 2014 |
Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Stomach Neoplasms | 2014 |
Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Nitroimidazoles; Probiotics; Proton Pump Inhibitors | 2015 |
Review article: the global emergence of Helicobacter pylori antibiotic resistance.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; China; Clarithromycin; Drug Resistance, Microbial; Female; Global Health; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Prevalence; Treatment Failure; Treatment Outcome | 2016 |
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Bismuth; Canada; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Tetracycline | 2016 |
Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis.
Topics: Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Proton Pump Inhibitors; Quinolones | 2017 |
Novel and Effective Therapeutic Regimens for
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Mutation; Prevalence; Probiotics; Proton Pump Inhibitors; Pyrroles; Rifabutin; Sulfonamides; Tetracycline; Tetracycline Resistance | 2017 |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Asia; Clarithromycin; Disease Eradication; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Pacific Islands; Prevalence; Tetracycline | 2017 |
Clinical Inquiries: What's the best secondary treatment for patients who fail initial triple therapy for H pylori?
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Practice Guidelines as Topic; Proton Pump Inhibitors; Randomized Controlled Trials as Topic | 2018 |
Toward population specific and personalized treatment of Helicobacter pylori infection.
Topics: Algorithms; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Models, Theoretical | 2018 |
Systematic review: Would susceptibility-guided treatment achieve acceptable cure rates for second-line Helicobacter pylori therapy as currently practiced?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Endoscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Treatment Outcome | 2019 |
Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Canada; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Practice Guidelines as Topic; Proton Pump Inhibitors; Rifabutin; Tetracycline; United States | 2019 |
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Proton Pump Inhibitors; Singapore | 2021 |
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Biopsy; Bismuth; Breath Tests; Clarithromycin; Culture Techniques; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Feces; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Nitro Compounds; Organometallic Compounds; Peptic Ulcer; Polymerase Chain Reaction; Proton Pump Inhibitors; Rifabutin; Salicylates; Salvage Therapy; Serologic Tests; Stomach Neoplasms; Tetracycline; Thiazoles; Treatment Outcome; Urea | 2020 |
Treatment of Helicobacter pylori infection: a clinical practice update.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Macrolides; Meta-Analysis as Topic; Practice Guidelines as Topic; Probiotics; Proton Pump Inhibitors; Salvage Therapy; Systematic Reviews as Topic | 2021 |
Efficacy of second-line regimens for
Topics: Adult; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Network Meta-Analysis; Outcome Assessment, Health Care; Practice Guidelines as Topic; Proton Pump Inhibitors; Quinolones; Randomized Controlled Trials as Topic; Tetracycline | 2020 |
[Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Russia | 2020 |
Levofloxacin-based therapy as an efficient alternative for eradicating Helicobacter pylori infection in Iran: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Levofloxacin | 2022 |
Diagnosis and Treatment of
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole | 2022 |
Helicobacter pylori Antibiotic Resistance in the United States Between 2011 and 2021: A Systematic Review and Meta-Analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Rifabutin; Tetracycline; United States | 2022 |
Clinical relevance of the cagA and vacA s1m1 status and antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Resistance, Microbial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole | 2022 |
Host Cell Antimicrobial Responses against
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Tetracycline; Virulence Factors | 2022 |
Antibiotic Resistance of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline; Turkey | 2023 |
Primary antibiotic resistance in Helicobacter pylori in China: a systematic review and meta-analysis.
Topics: Adult; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole | 2023 |
56 trial(s) available for clarithromycin and levofloxacin
| Article | Year |
|---|---|
Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Sinusitis; Treatment Outcome | 1998 |
A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Treatment Outcome | 2002 |
Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bronchitis, Chronic; Cefuroxime; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2002 |
[Community-acquired pneumonia: usefulness of clinical presentation in the selection of antibiotic treatment].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Community-Acquired Infections; Female; Hospitalization; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Ofloxacin; Penicillins; Pneumonia, Bacterial; Treatment Outcome | 2002 |
High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levofloxacin, for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Omeprazole; Rabeprazole; Treatment Outcome | 2004 |
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Organometallic Compounds; Pantoprazole; Prospective Studies; Sulfoxides; Treatment Outcome | 2004 |
Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Progression; Double-Blind Method; Female; Germany; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Statistics, Nonparametric; Treatment Outcome | 2004 |
Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Cohort Studies; Community-Acquired Infections; Drug Therapy, Combination; Female; Hospitalization; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 2005 |
7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2006 |
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
Rifaximin-based regimens for eradication of Helicobacter pylori: a pilot study.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pilot Projects; Rifamycins; Rifaximin; Treatment Outcome | 2006 |
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2006 |
Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease.
Topics: Amoxicillin; Anti-Infective Agents; Cefuroxime; Clarithromycin; Female; Follow-Up Studies; Forced Expiratory Volume; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Oximetry; Pulmonary Disease, Chronic Obstructive; Quality of Life; Recurrence; Survival Rate; Time Factors; Treatment Outcome | 2007 |
Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Levofloxacin; Male; Middle Aged; Ofloxacin; Rabeprazole; Tinidazole; Treatment Outcome | 2007 |
Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Constipation; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Nausea; Ofloxacin; Treatment Outcome; Vomiting | 2007 |
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure; Urea | 2008 |
Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Ofloxacin; Pneumonia; Treatment Outcome | 2007 |
Failure of Helicobacter pylori treatment after regimes containing clarithromycin: new practical therapeutic options.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Doxycycline; Female; Furazolidone; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Organometallic Compounds; Prospective Studies; Rabeprazole; Treatment Failure; Treatment Outcome; Urea | 2008 |
Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong?
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin | 2009 |
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Lansoprazole; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome | 2010 |
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Treatment Outcome; Young Adult | 2010 |
Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Cross-Over Studies; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Treatment Outcome; Young Adult | 2010 |
Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Single-Blind Method; Young Adult | 2010 |
Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2010 |
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Costs; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome; Young Adult | 2010 |
Efficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Peptic Ulcer; Prospective Studies; Rifamycins; Rifaximin | 2011 |
A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Lansoprazole; Levofloxacin; Male; Middle Aged; Nitro Compounds; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Recurrence; Thiazoles; Young Adult | 2011 |
Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication: a single-blind randomized clinical trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors; Single-Blind Method; Spain; Time Factors; Treatment Outcome; Urea; Young Adult | 2012 |
Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Failure | 2013 |
Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study.
Topics: Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Omeprazole; Pilot Projects; Proton Pump Inhibitors; Tinidazole; Urea | 2013 |
Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salvage Therapy; Spain; Surveys and Questionnaires; Tetracycline; Time Factors; Treatment Failure | 2014 |
Efficacy of PPI, levofloxacin and amoxicillin in the eradication of Helicobacter pylori compared to conventional triple therapy at a Venezuelan hospital.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Proton Pump Inhibitors; Venezuela; Young Adult | 2013 |
Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Treatment Outcome; Urea | 2015 |
Comparison of levofloxacin- and moxifloxacin-based triple therapies with standard treatment in eradication of Helicobacter pylori as first-line therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2014 |
The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Dental Amalgam; Dental Restoration, Permanent; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Levofloxacin; Male; Metronidazole; Middle Aged; Outpatients; Prospective Studies; Rabeprazole; Tetracycline; Treatment Outcome; Turkey; Urea | 2015 |
High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand.
Topics: Anti-Bacterial Agents; Antidiarrheals; Bismuth; Breath Tests; Clarithromycin; Cytochrome P-450 CYP2C19; Dexlansoprazole; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salicylates; Thailand | 2015 |
Two-week Triple Therapy with either Standard or High-dose Esomeprazole for First-line H. pylori Eradication.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Italy; Levofloxacin; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Time Factors; Treatment Outcome | 2016 |
Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial.
Topics: Adult; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Proton Pump Inhibitors; Treatment Outcome | 2017 |
Ten days of levofloxacin-containing concomitant therapy can achieve effective Helicobacter pylori eradication in patients with type 2 diabetes.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diabetes Mellitus, Type 2; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Tetracycline; Treatment Outcome | 2017 |
Helicobacter pylori Eradication With Levofloxacin or Clarithromycin in Dialysis Versus Nonuremic Patients.
Topics: Adult; Antigens, Bacterial; Clarithromycin; Double-Blind Method; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Levofloxacin; Male; Middle Aged; Renal Dialysis; Time Factors; Treatment Outcome; Uremia | 2017 |
Quadruple, sequential, and concomitant first-line therapies for H. pylori eradication: a prospective, randomized study.
Topics: Adult; Aged; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors | 2018 |
Efficacy of Reduced Dosage of Amoxicillin in an Eradication Therapy for Helicobacter pylori Infection in Patients on Hemodialysis: A Randomized Controlled Trial.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Levofloxacin; Male; Middle Aged; Prevalence; Renal Dialysis; Treatment Outcome | 2018 |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteriological Techniques; Breath Tests; Clarithromycin; Clinical Decision-Making; Doxycycline; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Predictive Value of Tests; Proton Pump Inhibitors; Taiwan; Tetracycline; Time Factors; Treatment Outcome | 2018 |
New fecal test for non-invasive
Topics: Adult; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Cross-Sectional Studies; DNA, Bacterial; Drug Resistance, Bacterial; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Point Mutation; Predictive Value of Tests; Prospective Studies; Reference Standards; Sensitivity and Specificity | 2018 |
Comparison between daily single-dose triple therapy and conventional triple therapy on patient compliance and Helicobacter pylori eradication: A randomized controlled trial.
Topics: Adult; Amoxicillin; Clarithromycin; Dysgeusia; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Patient Compliance; Tinidazole; Treatment Failure; Treatment Outcome; Young Adult | 2018 |
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2019 |
Is tailored therapy based on antibiotic susceptibility effective ? a multicenter, open-label, randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; China; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Outcome | 2020 |
Susceptibility-guided quadruple therapy is not superior to medication history-guided therapy for the rescue treatment of Helicobacter pylori infection: A randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Treatment Outcome | 2020 |
Comparing the Efficacy of Sequential and Standard Quadruple Therapy for Eradication of H. Pylori Infection.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Omeprazole; Organometallic Compounds; Tinidazole | 2020 |
Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Prevalence; Republic of Korea; Tertiary Care Centers | 2023 |
Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial.
Topics: Adult; Anti-Bacterial Agents; Australia; Bismuth; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; RNA, Ribosomal, 16S; Young Adult | 2023 |
Tailored triple plus bismuth therapy based on previous antibiotic medication history for first-line Helicobacter pylori eradication: A randomized trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Macrolides; Metronidazole; Proton Pump Inhibitors; Quinolones; Treatment Outcome | 2023 |
Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; COVID-19; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Pandemics; Proton Pump Inhibitors; Treatment Outcome | 2023 |
Quantitative PCR of string-test collected gastric material: A feasible approach to detect Helicobacter pylori and its resistance against clarithromycin and levofloxacin for susceptibility-guided therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Polymerase Chain Reaction; Retrospective Studies; Treatment Outcome | 2023 |
Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; RNA, Ribosomal, 23S | 2023 |
Susceptibility-guided sequential strategy versus empirical therapy for Helicobacter pylori infection: study protocol for a randomised controlled trial.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Prospective Studies; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2023 |
250 other study(ies) available for clarithromycin and levofloxacin
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of 7-(2-aminoalkyl)morpholinoquinolones as anti-Helicobacter pylori agents.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Drug Stability; Fluoroquinolones; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Indicators and Reagents; Microbial Sensitivity Tests; Molecular Structure; Naphthyridines; Ofloxacin; Quinolones; Solutions; Structure-Activity Relationship; Ultraviolet Rays | 1998 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents.
Topics: Amidohydrolases; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Peptides; Pneumococcal Infections; Species Specificity; Streptococcus pneumoniae; Time Factors | 2007 |
Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea.
Topics: Ampicillin Resistance; beta-Lactamases; Drug Resistance, Bacterial; Genes, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Korea; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Species Specificity | 2007 |
Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Macrolides; Microbial Sensitivity Tests; Mycoplasma pneumoniae | 2007 |
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Korea; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Ofloxacin; Pneumococcal Infections; Polymerase Chain Reaction; Prevalence; Reserpine; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae | 2007 |
Genetic characteristics and clonal dissemination of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan.
Topics: Adolescent; Adult; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Child; Child, Preschool; Female; Gene Frequency; Genotype; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymerase Chain Reaction; Respiratory Tract Infections | 2007 |
In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan.
Topics: Animals; Aza Compounds; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Humans; Japan; Levofloxacin; Liver; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolines; Spleen | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Imipenem; Ketolides; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae | 2007 |
Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Infant; Infant, Newborn; Macrolides; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; RNA, Ribosomal, 23S | 2008 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Molecular Structure; Pleuromutilins; Polycyclic Compounds; Solubility; Stereoisomerism; Water | 2008 |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl beta-aldehyde ketone derivatives.
Topics: Aldehydes; Anti-Bacterial Agents; Bacteria; Drug Design; Ketones; Structure-Activity Relationship | 2009 |
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Pigmentation; Species Specificity; Tigecycline | 2008 |
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Female; Genetic Heterogeneity; Humans; Infant, Newborn; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Phylogeny; Sequence Analysis, DNA; Streptococcus agalactiae | 2008 |
Site-directed mutagenesis reveals amino acid residues in the Escherichia coli RND efflux pump AcrB that confer macrolide resistance.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Macrolides; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Mutagenesis, Site-Directed; Sequence Homology, Amino Acid | 2009 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Child; China; Drug Resistance, Bacterial; Genes, rRNA; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Respiratory Tract Infections; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2009 |
Comparative antipneumococcal activities of sulopenem and other drugs.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Lactams; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Streptococcus pneumoniae | 2009 |
Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections.
Topics: Adolescent; Adult; Aged; Bacterial Capsules; Child; Child, Preschool; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant; Infant, Newborn; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Polymerase Chain Reaction; Streptococcus agalactiae | 2009 |
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
Topics: Anti-Bacterial Agents; China; Cities; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2009 |
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
Topics: Microbial Sensitivity Tests; Mycoplasma genitalium; Polymerase Chain Reaction | 2009 |
Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance.
Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Amino Acid Substitution; Ampicillin; Ampicillin Resistance; beta-Lactamases; Child; Child, Preschool; DNA, Bacterial; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Korea; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Penicillin-Binding Proteins; Population Surveillance; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Serotyping; Young Adult | 2010 |
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Macrolides; Microbial Sensitivity Tests; Penicillin G; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Minocycline; Neisseria meningitidis; Penicillins; Rifampin; Sulfamethoxazole; Triazoles; Trimethoprim | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.
Topics: Anti-Infective Agents; Azithromycin; Chlamydia trachomatis; Clarithromycin; Doxycycline; Erythromycin; Genotype; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Design, synthesis, and biological evaluations of novel 7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens.
Topics: Animals; Anti-Bacterial Agents; Drug Design; Fluoroquinolones; Haemophilus influenzae; Male; Mice; Microbial Sensitivity Tests; Quinolones; Rats; Respiratory Tract Infections; Spiro Compounds; Staphylococcus aureus; Streptococcus pneumoniae | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bambermycins; Drug Design; Drug Resistance, Multiple, Bacterial; Duodenal Ulcer; Enzyme Inhibitors; Gastritis; Glycosyltransferases; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Molecular Conformation; Stomach Neoplasms; Stomach Ulcer | 2014 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Design, synthesis and structure-activity relationships of novel 15-membered macrolides: Quinolone/quinoline-containing sidechains tethered to the C-6 position of azithromycin acylides.
Topics: Anti-Bacterial Agents; Azithromycin; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Design; Escherichia coli; Macrolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Quinolines; Quinolones; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2020 |
Levofloxacin in patients with severe respiratory tract infection.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Asthma; Bronchitis; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pseudomonas aeruginosa; Respiratory Tract Infections | 1995 |
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Clarithromycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Streptococcus pneumoniae | 1996 |
[Measurement of antibody titers to chlamydial infection and effects of levofloxacin in cystic cervicitis and chlamydial infection].
Topics: Actihaemyl; Administration, Oral; Adolescent; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Chlamydia Infections; Chlamydia trachomatis; Chloramphenicol; Clarithromycin; Drug Therapy, Combination; Female; Humans; Immunoglobulin A; Immunoglobulin G; Levofloxacin; Middle Aged; Ofloxacin; Pessaries; Pregnancy; Pregnancy Complications, Infectious; Uterine Cervicitis | 1997 |
[Anti-Mycobacterium avium complex activities of KRM-1648, clarithromycin and levofloxacin in 7HSF medium at peak or average blood concentrations after their oral administration of clinical dosages].
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Clarithromycin; Culture Media; Humans; Levofloxacin; Mycobacterium avium Complex; Ofloxacin; Rifamycins | 1997 |
[In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antitubercular; Clarithromycin; Diclofenac; Drug Therapy, Combination; Female; Levofloxacin; Mice; Mice, Inbred BALB C; Mycobacterium avium; Ofloxacin; Rifamycins; Tuberculosis | 1997 |
Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Sensitivity and Specificity; Species Specificity; Streptococcus pneumoniae | 1997 |
In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; In Vitro Techniques; Legionella; Legionella pneumophila; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 1997 |
Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Clarithromycin; Cohort Studies; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Ofloxacin; Respiratory Tract Infections; Streptococcus pneumoniae; United States | 1997 |
Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Female; Levofloxacin; Lung; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium avium; Ofloxacin; Phagocytosis; Rifamycins; Tuberculosis | 1998 |
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae | 1998 |
Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologies.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbon Dioxide; Clarithromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae | 1998 |
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Topics: Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
[MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Cells, Cultured; Clarithromycin; Humans; Levofloxacin; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Ofloxacin; Pulmonary Alveoli; Rifamycins | 1999 |
[Fibrosing alveolitis following Legionella pneumonia].
Topics: Anti-Inflammatory Agents; Clarithromycin; Drug Therapy, Combination; Humans; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Minocycline; Ofloxacin; Pulmonary Fibrosis; Pulse Therapy, Drug; Steroids; Treatment Outcome | 2000 |
Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation.
Topics: Animals; Biofilms; Chronic Disease; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Intubation; Levofloxacin; Male; Mice; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 2000 |
Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines.
Topics: Anti-Bacterial Agents; Cell Line; Clarithromycin; Epithelial Cells; Humans; Levofloxacin; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis; Ofloxacin; Pulmonary Alveoli; Rifamycins; Tuberculosis | 2000 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
Effect of levofloxacin on theophylline clearance during theophylline and clarithromycin combination therapy.
Topics: Anti-Infective Agents; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Emphysema; Humans; Levofloxacin; Male; Metabolic Clearance Rate; Middle Aged; Ofloxacin; Theophylline | 2001 |
Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model.
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydophila pneumoniae; Clarithromycin; Cytokines; Humans; Levofloxacin; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Tumor Cells, Cultured | 2002 |
Intramacrophage passage of Mycobacterium tuberculosis and M. avium complex alters the drug susceptibilities of the organisms as determined by intracellular susceptibility testing using macrophages and type II alveolar epithelial cells.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cells, Cultured; Clarithromycin; Epithelial Cells; Humans; Levofloxacin; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Ofloxacin; Rifamycins | 2002 |
[Changes of antibody titers during antimicrobial therapy including levofloxacin for Chlamydia infections in the obstetrics and gynecology field].
Topics: Antibodies, Bacterial; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Levofloxacin; Maternal-Fetal Exchange; Ofloxacin; Pregnancy; Pregnancy Complications, Infectious | 2002 |
[Osteomyelitis of the tibial head caused by Mycobacterium haemophilium in a patient with AIDS].
Topics: Abscess; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Mycobacterium haemophilum; Mycobacterium Infections; Ofloxacin; Osteomyelitis; Recurrence; Rifabutin; Tibia | 2002 |
[Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Gastric Mucosa; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Penicillins; Stomach Ulcer | 2002 |
Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting.
Topics: Adolescent; Adult; Aged; Alberta; Ambulatory Care; Analysis of Variance; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Emergency Service, Hospital; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2003 |
[A case of pulmonaly bulla infection with Mycobacterium fortuitum].
Topics: Aged; Blister; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Levofloxacin; Lung Diseases, Interstitial; Minocycline; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Pulmonary Emphysema | 2003 |
Alterations in penicillin binding protein gene of Streptococcus pneumoniae and their correlation with susceptibility patterns.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carrier Proteins; Clarithromycin; Drug Resistance, Bacterial; Genes, Bacterial; Hexosyltransferases; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Ofloxacin; Penicillin G; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumococcal Infections; Streptococcus pneumoniae; Thienamycins | 2003 |
[Susceptibility of major pathogens of acute pharyngitis and tonsillitis to levofloxacin and other oral antimicrobial drugs].
Topics: Acute Disease; Ampicillin; Anti-Infective Agents; Azithromycin; Cefdinir; Cefpodoxime; Ceftizoxime; Cephalosporins; Clarithromycin; Enterobacteriaceae; Haemophilus influenzae; Humans; Levofloxacin; Ofloxacin; Penicillin G; Pharyngitis; Streptococcus pneumoniae; Streptococcus pyogenes; Tonsillitis | 2003 |
Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure | 2003 |
[Sporotrichoid atypical mycobacterial infections. Antibiotic monotherapy].
Topics: Adult; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Female; Forearm; Hand Dermatoses; Humans; Levofloxacin; Lymphadenitis; Male; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Ofloxacin; Skin; Skin Diseases, Bacterial; Sporotrichosis; Treatment Outcome | 2004 |
Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Arrhythmias, Cardiac; Case-Control Studies; Ciprofloxacin; Clarithromycin; Cohort Studies; Community Health Planning; Databases, Factual; Drug Monitoring; Erythromycin; Humans; Italy; Levofloxacin; Miocamycin; Norfloxacin; Ofloxacin; Pharmacoepidemiology; Risk Factors | 2005 |
High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy.
Topics: Clarithromycin; Drug Resistance; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Nitroimidazoles; Ofloxacin; Proton Pump Inhibitors; Treatment Failure | 2004 |
An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Databases as Topic; Erythromycin; Female; Health Care Costs; Humans; Levofloxacin; Male; Managed Care Programs; Middle Aged; Models, Econometric; Ofloxacin; Pneumonia, Bacterial; Retrospective Studies; Risk Assessment; Treatment Outcome | 2005 |
[The clinical study on efficacy of clarithromycin, levofloxacin, and streptomycin for pulmonary Mycobacterium avium-intracellulare complex infection].
Topics: Aged; Anti-Bacterial Agents; Blood Sedimentation; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Ofloxacin; Radiography, Thoracic; Retrospective Studies; Streptomycin | 2005 |
In vitro selection of resistance to clarithromycin in Streptococcus pneumoniae clinical isolates.
Topics: Amoxicillin; Aza Compounds; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Sampling Studies; Sensitivity and Specificity; Streptococcus pneumoniae | 2005 |
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Synergism; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2005 |
[Assessment of the management of community-acquired pneumonia in adults outpatients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Chi-Square Distribution; Clarithromycin; Community-Acquired Infections; Emergencies; Female; Frail Elderly; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Prospective Studies; Treatment Failure | 2005 |
[Prevalence and treatment of pharyngeal Chlamydia trachomatis infections].
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Female; Humans; Japan; Levofloxacin; Ofloxacin; Pharyngitis; Prevalence; Sex Work; Sexual Behavior; Uterine Diseases | 2006 |
Effects of antibacterial agents, levofloxacin and clarithromycin, on aquatic organisms.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Clarithromycin; Crustacea; Daphnia; Dose-Response Relationship, Drug; Environmental Pollutants; Levofloxacin; Models, Chemical; Ofloxacin; Risk; Toxicity Tests, Acute; Water Pollutants, Chemical; Water Purification | 2006 |
Occurrence of levofloxacin, clarithromycin and azithromycin in wastewater treatment plant in Japan.
Topics: Anti-Bacterial Agents; Azithromycin; Chromatography, Liquid; Clarithromycin; Conservation of Natural Resources; Japan; Levofloxacin; Mass Spectrometry; Ofloxacin; Sewage; Time Factors; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification | 2006 |
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment.
Topics: Amoxicillin; Ampicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Omeprazole; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
[A case of Mycobacterium fortuitum meningitis following surgery for meningioma].
Topics: Clarithromycin; Female; Humans; Levofloxacin; Meningeal Neoplasms; Meningioma; Meningitis, Bacterial; Middle Aged; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Postoperative Complications | 2006 |
Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome | 2007 |
Levofloxacin in first-line treatment of Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Ofloxacin; Treatment Outcome | 2007 |
Levofloxacin-resistant Helicobacter pylori in Hong Kong.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA Gyrase; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Ketolides; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Point Mutation; Tetracycline | 2008 |
[Case of pneumothorax associated with pulmonary Mycobacterium fortuitum infection].
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Combined Modality Therapy; Drainage; Drug Resistance, Bacterial; Humans; Levofloxacin; Male; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Pneumonectomy; Pneumothorax; Recurrence; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Case-Control Studies; Chi-Square Distribution; Clarithromycin; Colony Count, Microbial; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Tetracycline Resistance; Treatment Failure | 2008 |
[Levofloxacin and macrolides in chronic bronchitis exacerbation: comparative analysis of the treatment efficacy and nonrelapsing periods].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Bronchitis, Chronic; Clarithromycin; Female; Humans; Levofloxacin; Macrolides; Male; Middle Aged; Ofloxacin; Treatment Outcome; Young Adult | 2007 |
Levofloxacin-induced delirium.
Topics: Age Factors; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Brain; Clarithromycin; Confusion; Delirium; Ertapenem; Hallucinations; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia; Risk Factors; Sex Factors; Time Factors; Withholding Treatment | 2009 |
[Antimicrobial resistance of 36 strains of Helicobacter pylori in adolescents].
Topics: Adolescent; Amoxicillin; Anti-Infective Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Female; Gastroscopy; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Ofloxacin | 2009 |
Seven-day PPI-triple therapy with levofloxacin is very effective for Helicobacter pylori eradication.
Topics: Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors | 2009 |
Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Asian People; Child; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Patient Selection; Prevalence; Taiwan; Time Factors; Treatment Failure; Young Adult | 2009 |
Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Penicillins; Prospective Studies; Treatment Outcome | 2010 |
Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Nucleic Acid Hybridization; Ofloxacin; Point Mutation; Predictive Value of Tests; Sensitivity and Specificity; Sequence Deletion | 2009 |
Helicobacter pylori antibiotic resistance and [13C]urea breath test values.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Statistics as Topic; Urea; Urease | 2010 |
Antibiotic resistance of Helicobacter pylori in Israeli children.
Topics: Adolescent; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Biopsy; Chi-Square Distribution; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Israel; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Prospective Studies; Surveys and Questionnaires; Tetracycline; Treatment Failure | 2010 |
Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study.
Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Chi-Square Distribution; Clarithromycin; Community-Acquired Infections; Female; Humans; Kaplan-Meier Estimate; Legionella pneumophila; Legionnaires' Disease; Length of Stay; Levofloxacin; Male; Ofloxacin; Retrospective Studies; Time Factors; Treatment Outcome | 2010 |
Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication?
Topics: Adolescent; Adult; Aged; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Tinidazole; Young Adult | 2010 |
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline | 2010 |
Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Clarithromycin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lebanon; Levofloxacin; Male; Ofloxacin; Pneumococcal Infections; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Vancomycin | 2010 |
Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Retrospective Studies; Young Adult | 2010 |
Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies.
Topics: Adult; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Randomized Controlled Trials as Topic; RNA, Ribosomal, 23S; Treatment Outcome | 2011 |
Levofloxacin in first-line eradication regimens for Helicobacter pylori: better test antibiotic susceptibility before treating.
Topics: Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Ofloxacin | 2011 |
Sequential therapy for Helicobacter pylori eradication: is levofloxacin better?
Topics: Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Ofloxacin | 2011 |
In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bridged-Ring Compounds; Cell Line; Cells, Cultured; Clarithromycin; Disease Models, Animal; Humans; Ketolides; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Macrolides; Mice; Microbial Sensitivity Tests; Ofloxacin | 2011 |
[Regional difference of antibiotic resistance of helicobacter pylori strains in Korea].
Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Republic of Korea; Tetracycline | 2011 |
Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Doxycycline; Erythromycin; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Reproducibility of Results; Roxithromycin; Tetracycline; Time Factors; Ureaplasma Infections; Ureaplasma urealyticum | 2011 |
High Helicobacter pylori resistance to metronidazole but zero or low resistance to clarithromycin, levofloxacin, and other antibiotics in Malaysia.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies | 2011 |
Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Poland | 2011 |
Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Dyspepsia; Endoscopy; England; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Risk Factors; Wales | 2012 |
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Utilization; Europe; Female; Helicobacter pylori; Humans; Infant; Infant, Newborn; Levofloxacin; Linear Models; Logistic Models; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Ofloxacin; Prospective Studies; Risk Factors; Surveys and Questionnaires; Young Adult | 2013 |
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Logistic Models; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Spain; Surveys and Questionnaires; Time Factors; Treatment Failure | 2013 |
Pulmonary Mycobacterium kyorinense disease showed clinical improvement following combined therapy with clarithromycin and levofloxacin.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Tuberculosis, Pulmonary | 2012 |
Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Clarithromycin; Comorbidity; Disease Eradication; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors; Retrospective Studies; Tinidazole; Treatment Outcome; Ulcer; Young Adult | 2012 |
Cumulative Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Obesity, Morbid; Ofloxacin; Portugal; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Factors; Stomach Neoplasms; Surgical Wound Infection; Treatment Failure; Young Adult | 2013 |
High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2012 |
Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Ofloxacin; RNA, Ribosomal, 23S; Senegal; Tetracycline; Young Adult | 2013 |
Education and imaging. Gastrointestinal: colonic mucosa-associated lymphoid tissue lymphoma regressed by levofloxacin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colonic Neoplasms; Colonoscopy; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Endosonography; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Lansoprazole; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Multimodal Imaging; Occult Blood; Ofloxacin; Polymerase Chain Reaction; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Anti-inflammatory effects of clarithromycin in ventilator-induced lung injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Inflammation Mediators; Levofloxacin; Lung; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Ventilator-Induced Lung Injury | 2013 |
Clinical outcome of the chronic flexor tenosynovitis in the hand caused by non-tuberculous mycobacterium treated by extensive tenosynovectomy and drugs.
Topics: Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Hand; Hand Strength; Humans; Immunocompetence; Isoniazid; Levofloxacin; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Mycobacterium marinum; Osteomyelitis; Range of Motion, Articular; Retrospective Studies; Rifampin; Scaphoid Bone; Synovectomy; Tenosynovitis | 2013 |
Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Disease Eradication; DNA Gyrase; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Prospective Studies; Proton Pump Inhibitors; RNA, Ribosomal, 23S; Treatment Failure | 2014 |
Visualization of the meibomian glands by means of noncontact mobile-type meibography (Meibopen) in a 16-year-old girl with unilateral marginal staphylococcal keratitis.
Topics: Administration, Oral; Administration, Topical; Adolescent; Anti-Bacterial Agents; Clarithromycin; Corneal Ulcer; Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Eye Infections, Bacterial; Eyelid Diseases; Female; Fluorometholone; Humans; Levofloxacin; Meibomian Glands; Staphylococcal Infections; Visual Acuity | 2014 |
[Case report; Disseminated Mycobacterium abscessus infection with hemophagocytic syndrome during treatment of chronic lymphocytic leukemia].
Topics: Amikacin; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Clarithromycin; Cyclophosphamide; Humans; Imipenem; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Levofloxacin; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Prednisolone; Treatment Outcome | 2014 |
Case of disseminated cutaneous Mycobacterium chelonae infection mimicking cutaneous vasculitis.
Topics: Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Female; Humans; Immunocompromised Host; Levofloxacin; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Vasculitis | 2014 |
Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Drug Interactions; Drug Prescriptions; Female; Glipizide; Glyburide; Health Care Costs; Humans; Hypoglycemia; Hypoglycemic Agents; Levofloxacin; Logistic Models; Male; Medicare; Metronidazole; Morbidity; Odds Ratio; Retrospective Studies; Risk Factors; Sulfonylurea Compounds; Texas; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2014 |
Fatal disseminated infection with Fusarium petroliphilum.
Topics: Amphotericin B; Antifungal Agents; Cefepime; Cephalosporins; Clarithromycin; Drug Resistance, Fungal; Female; Fusariosis; Fusarium; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Mycological Typing Techniques; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Metronidazole; Middle Aged; Omeprazole; Penicillins; Predictive Value of Tests; Prospective Studies; Proton Pump Inhibitors; Rifabutin; Salvage Therapy; Spain; Tetracycline; Time Factors; Treatment Outcome | 2015 |
Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; beta-Lactamase Inhibitors; Cardiovascular Diseases; Ciprofloxacin; Clarithromycin; Comorbidity; Female; Fluoroquinolones; Humans; Levofloxacin; Logistic Models; Male; Moxifloxacin; Risk; Taiwan | 2015 |
Trends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned?
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Prevalence; Retrospective Studies; Time Factors; Young Adult | 2015 |
High rate of levofloxacin resistance in a background of clarithromycin- and metronidazole-resistant Helicobacter pylori in Vietnam.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Point Mutation; RNA, Ribosomal, 23S; Tertiary Care Centers; Vietnam; Young Adult | 2015 |
The evolution of Helicobacter pylori antibiotics resistance over 10 years in Greece.
Topics: Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Gene Frequency; Greece; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Molecular Epidemiology; Mutation; Polymorphism, Single Nucleotide; Prevalence; Retrospective Studies; RNA, Ribosomal, 23S | 2014 |
[Resistance surveillance of major pathogens for adult community-acquired respiratory tract infections in China: a multicenter study 2012].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cephalosporins; China; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillins; Respiratory Tract Infections; Streptococcus pneumoniae | 2015 |
Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Buruli Ulcer; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Humans; Japan; Levofloxacin; Male; Middle Aged; Rifampin; Young Adult | 2015 |
Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Middle Aged; Nitroimidazoles; Pantoprazole; Portugal; Prospective Studies; Proton Pump Inhibitors; Treatment Failure; Young Adult | 2015 |
Increase in SCCmec type IV strains affects trends in antibiograms of meticillin-resistant Staphylococcus aureus at a tertiary-care hospital.
Topics: Bacterial Toxins; Bacterial Typing Techniques; Cefotaxime; Chromosomes, Bacterial; Clarithromycin; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterotoxins; Exotoxins; Humans; Interspersed Repetitive Sequences; Japan; Leukocidins; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Staphylococcal Infections; Superantigens; Tertiary Care Centers; Virulence Factors | 2015 |
A Case of Pulmonary Actinomycosis Associated With Aspiration of Cedar Leaves.
Topics: Actinomyces; Actinomycosis; Anti-Bacterial Agents; Biopsy; Bronchoscopy; Cedrus; Clarithromycin; Female; Foreign Bodies; Humans; Levofloxacin; Lung Abscess; Lung Diseases; Middle Aged; Rare Diseases; Tomography, X-Ray Computed | 2015 |
Prevalence of Primary Resistance of Helicobacter pylori to Clarithromycin and Levofloxacin in Southern Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Disease Eradication; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymerase Chain Reaction; Prevalence; RNA, Bacterial; RNA, Ribosomal, 23S; Spain; Young Adult | 2015 |
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Bacterial; Barrett Esophagus; Bismuth; Breath Tests; Clarithromycin; Disease Management; Drug Therapy, Combination; Dyspepsia; Feces; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Italy; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Stomach Neoplasms; Urea | 2015 |
Linezolid susceptibility in Helicobacter pylori, including strains with multidrug resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Linezolid; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2015 |
Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies; Taiwan; Tetracycline; Time Factors | 2015 |
Helicobacter pylori resistance to six antibiotics by two breakpoint systems and resistance evolution in Bulgaria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bulgaria; Child; Clarithromycin; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2016 |
[A CASE OF PULMONARY MYCOBACTERIUM ABSCESSUS INFECTION SUCCESSFULLY TREATED WITH SHORT-TERM CAM, AMK, AND IPM/cs FOLLOWED BY LONG-TERM ORAL CAM AND LVFX].
Topics: Administration, Oral; Aged; Amikacin; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Female; Humans; Imipenem; Levofloxacin; Lung Diseases; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2015 |
Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Longitudinal Studies; Metronidazole; Omeprazole; Prospective Studies; Rifabutin; Tetracycline; Treatment Failure | 2015 |
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Child; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Fluoroquinolones; Gastric Fundus; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pyloric Antrum; Rifabutin; Tetracycline; Young Adult | 2016 |
[Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014].
Topics: Anti-Bacterial Agents; Aza Compounds; Cefepime; Cephalosporins; China; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Fluoroquinolones; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Penicillins; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae | 2016 |
Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Biological Assay; Biological Transport; Cell Membrane; Cephalosporins; Clarithromycin; Drug Synergism; Escherichia coli; Escherichia coli Proteins; Fluorescent Dyes; Gene Expression; Imidazoles; Indicators and Reagents; Kinetics; Levofloxacin; Linezolid; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Oxacillin; Piperazines; Protein Kinases; Repressor Proteins; Rifampin | 2016 |
Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Retreatment; Treatment Outcome | 2016 |
The relationship between the failure to eradicate Helicobacter pylori and previous antibiotics use.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Hospitals, Teaching; Humans; Levofloxacin; Logistic Models; Macrolides; Male; Middle Aged; Multivariate Analysis; Republic of Korea; Retrospective Studies; Tertiary Care Centers | 2016 |
[Antibiotic resistance of Helicobacter pylori clinical isolates in Hebei Province].
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Microbial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole | 2016 |
The Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Biopsy; China; Clarithromycin; Drug Resistance, Bacterial; Female; Furazolidone; Gastroscopy; Gentamicins; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged | 2016 |
Multiple drug allergy: A case of anaphylaxis to levofloxacin but tolerance to ciprofloxacin.
Topics: Adolescent; Amoxicillin; Anaphylaxis; Ciprofloxacin; Clarithromycin; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Levofloxacin; Male; Tonsillitis | 2016 |
Primary resistance of Helicobacter pylori is still low in Southern Austria.
Topics: Adult; Aged; Anti-Bacterial Agents; Austria; Clarithromycin; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Virulence Factors | 2016 |
[A CASE OF PULMONARY MYCOBACTERIUM ABSCESSUS INFECTION THAT DEVELOPED DURING IMMUNOSUPPRESSIVE THERAPY FOR MYASTHENIA GRAVIS WITH RECURRENT THYMOMA].
Topics: Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Levofloxacin; Male; Middle Aged; Myasthenia Gravis; Mycobacterium Infections, Nontuberculous; Neoplasm Recurrence, Local; Thymoma; Thymus Neoplasms; Treatment Outcome | 2016 |
Occurrence of Mutations in the Antimicrobial Target Genes Related to Levofloxacin, Clarithromycin, and Amoxicillin Resistance in Helicobacter pylori Isolates from Buenos Aires City.
Topics: Amoxicillin; Anti-Bacterial Agents; Argentina; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Point Mutation; RNA, Ribosomal, 23S | 2017 |
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Clarithromycin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Endoscopy; Female; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; High-Throughput Nucleotide Sequencing; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Nepal; Nitroreductases; Point Mutation; Prevalence; Prokaryotic Initiation Factor-2; RNA, Ribosomal, 23S; Tetracycline; Young Adult | 2016 |
Eradication Rate by Duration of Third-line Rescue Therapy with Levofloxacin after Helicobacter pylori Treatment Failure in Clinical Practice.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Treatment Failure | 2016 |
Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations.
Topics: Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Drug Resistance, Microbial; Endoscopy; Female; Frameshift Mutation; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Mutation, Missense; Point Mutation; RNA, Ribosomal, 23S | 2016 |
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Salvage Therapy; Treatment Failure | 2017 |
Letter: levofloxacin resistance - a challenge for the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Ofloxacin | 2017 |
Letter: levofloxacin resistance - a challenge for treatment of Helicobacter pylori infection. Authors' reply.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin | 2017 |
Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Portugal; Proton Pump Inhibitors; Retrospective Studies; Tinidazole; Treatment Outcome; Young Adult | 2017 |
Antibiotic susceptibility of Helicobacter pylori in Iceland.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Iceland; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Young Adult | 2017 |
The diagnosis and management of H. pylori infection in Singapore.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Singapore | 2017 |
Secondary antibiotic resistance of Helicobacter pylori isolates in Israeli children and adults.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies; Tetracycline; Young Adult | 2017 |
Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection.
Topics: Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Body Mass Index; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Tetracycline | 2017 |
Appraisal of the cardiovascular risks of azithromycin: an observational analysis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Clarithromycin; Female; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Retrospective Studies; Risk Factors; Young Adult | 2017 |
Antimicrobial susceptibility of Helicobacter pylori strains isolated from children in Israel.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2018 |
Cumulative Helicobacter Pylori Eradication Rates by Adopting First- and Second- Line Regimens Proposed by the Maastricht IV Consensus in Obese Patients Undergoing Gastric Bypass Surgery.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Consensus; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Obesity, Morbid; Prospective Studies; Proton Pump Inhibitors; Young Adult | 2018 |
Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study.
Topics: Adult; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Microbial Viability; Risk Factors | 2018 |
Inappropriate treatment in Helicobacter pylori eradication failure: a retrospective study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Treatment Failure; Young Adult | 2018 |
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Treatment Outcome | 2018 |
Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Incidence; Levofloxacin; Male; Middle Aged; Protective Factors; Proton Pump Inhibitors; Registries; Retrospective Studies; Risk Factors; Stomach Neoplasms | 2018 |
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged | 2018 |
Retrospective study on outcome of salvage Helicobacter pylori eradication therapies based on molecular genetic susceptibility testing.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Retrospective Studies; Salvage Therapy; Treatment Outcome; Young Adult | 2018 |
[Phylogenetic study of drug resistance genes from clinical isolates of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Phylogeny; Tetracycline; Tibet | 2018 |
The interplay between mutations in cagA, 23S rRNA, gyrA and drug resistance in Helicobacter pylori.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; RNA, Ribosomal, 23S | 2018 |
Helicobacter pylori antimicrobial resistance in a pediatric population.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Prospective Studies | 2018 |
Efficacy of standard triple therapy versus Levofloxacin based alternate therapy against Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Comparative Effectiveness Research; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Pakistan; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2018 |
Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline; Young Adult | 2018 |
Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Republic of Korea; Tetracycline; Young Adult | 2019 |
Refractory Helicobacter pylori gastritis: The hidden predictors of resistance.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Polymorphism, Restriction Fragment Length; Risk Factors; RNA, Ribosomal, 23S; Salvage Therapy | 2019 |
Influence of levofloxacin and clarithromycin on the structure of DPPC monolayers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adsorption; Air; Clarithromycin; Levofloxacin; Lipid Bilayers; Lipid Metabolism; Lipids; Membranes, Artificial; Microscopy; Models, Biological; Phospholipids; Pulmonary Surfactants; Spectrophotometry, Infrared; Surface Properties; Water | 2019 |
Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Risk Factors; Sex Factors; Tetracycline; Young Adult | 2020 |
Primary antimicrobial resistance rates and prevalence of Helicobacter pylori infection in the north of Spain. A 13-year retrospective study.
Topics: Age Factors; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Prevalence; Retrospective Studies; Sex Factors; Spain | 2019 |
Primary and secondary antibiotic resistance of Helicobacter pylori in Korea from 2003 to 2018.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Republic of Korea; Young Adult | 2019 |
Helicobacter pylori: Multiple resistance in patients from Bogotá, Colombia
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Colombia; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Gastroscopy; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged | 2019 |
β-Lactamase-non-producing ampicillin-resistant Haemophilus influenzae is acquiring multidrug resistance.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Clarithromycin; Drug Resistance, Multiple, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Sequence Analysis, DNA | 2020 |
Molecular detection of H. pylori antibiotic-resistant genes and molecular docking analysis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Mutation | 2020 |
Application of gene chip technology in the diagnostic and drug resistance detection of Helicobacter pylori in children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Gastric Mucosa; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Mutation; Oligonucleotide Array Sequence Analysis; Polymorphism, Single Nucleotide; Sensitivity and Specificity | 2020 |
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg).
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Hypersensitivity; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Registries; Tetracycline | 2020 |
[Helicobacter pylori infection. Frequency of first-line treatment failure].
Topics: Amoxicillin; Anti-Bacterial Agents; Argentina; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Retrospective Studies; Treatment Failure | 2020 |
Antibiotic resistance of Helicobacter pylori infection in a children's hospital in Vietnam: prevalence and associated factors.
Topics: Amoxicillin; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Peptic Ulcer; Tetracycline; Vietnam | 2020 |
Population-based study of Helicobacter pylori infection and antibiotic resistance in Bhutan.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bhutan; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Prevalence; Tetracycline | 2020 |
High rates of clarithromycin and levofloxacin resistance of Helicobacter pylori in patients with chronic gastritis in the south east area of Vietnam.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Vietnam | 2020 |
Antimicrobial resistance of Helicobacter pylori in an eastern German region.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests | 2021 |
Helicobacter pylori Eradication Rates in Slovenia in the Period from 2017 to 2019: Data from the European Registry on H. pylori Management.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Health Plan Implementation; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Registries; Slovenia | 2021 |
[Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Russia | 2020 |
Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests | 2020 |
Antimicrobial resistance of
Topics: Anti-Bacterial Agents; Belgium; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin | 2022 |
Prevalence of Helicobacter pylori Antimicrobial Resistance Among Chilean Patients.
Topics: Aged; Anti-Bacterial Agents; Chile; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence | 2021 |
Detection of Helicobacter pylori by invasive tests in adult dyspeptic patients and antibacterial resistance to six antibiotics, including rifampicin in Turkey. Is clarithromycin resistance rate decreasing?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Rifampin; Turkey; Young Adult | 2021 |
Culture-Based Antimicrobial Susceptibility Testing for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Culture Media; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin | 2021 |
Effectiveness of antibacterial agents against cell-invading bacteria such as Streptococcus pyogenes and Haemophilus influenzae.
Topics: Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Streptococcal Infections; Streptococcus pyogenes | 2021 |
Unacceptable Antibiotic Resistance Rates for Helicobacter pylori in Turkey: Something Must Change.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Turkey; Urease | 2021 |
Primary antibiotic resistance of Helicobacter pylori isolates is twofold more frequent in HIV-positive than HIV-negative individuals: A descriptive observational study.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; HIV Infections; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2021 |
Antimicrobial Resistance and the Successful Eradication of
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Asian People; Child; Child, Preschool; Clarithromycin; Disease Eradication; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Tetracycline | 2021 |
Minimum inhibitory concentrations of commonly used antibiotics against Helicobacter Pylori: A multicenter study in South China.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Tetracycline; Young Adult | 2021 |
Point Mutations at gyrA and gyrB Genes of Levofloxacin Resistant Helicobacter pylori Strains and Dual Resistance with Clarithromycin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Point Mutation | 2021 |
Comparison of Drug Resistance of Helicobacter pylori Between Children and Adults in Jilin, China.
Topics: Adult; Amoxicillin; Amplified Fragment Length Polymorphism Analysis; Anti-Bacterial Agents; Child; China; Clarithromycin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; RNA, Ribosomal, 16S; Tetracyclines | 2021 |
Establishment of a TaqMan-MGB probe multiplex real-time PCR system for one-step levofloxacin and clarithromycin resistant Helicobacter pylori detection.
Topics: Anti-Bacterial Agents; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S | 2022 |
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg).
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Penicillins; Prospective Studies; Proton Pump Inhibitors; Quinolones; Registries; Tetracycline | 2022 |
In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Biofilms; Biological Products; Catalytic Domain; Clarithromycin; Diosgenin; Drug Evaluation, Preclinical; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Binding; Protein Conformation; Pyrophosphatases; Virulence | 2021 |
Second-line Therapy for Helicobacter Pylori Eradication: State of the Art.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Tetracycline | 2022 |
Biofilm Formation of
Topics: Anti-Bacterial Agents; Biofilms; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Microfluidics | 2022 |
Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Protein Synthesis Inhibitors; Tetracycline | 2022 |
Direct Detection of Antibiotic Resistance in Chinese
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2022 |
Antibiotic resistance of Helicobacter pylori isolated from children in Chongqing, China.
Topics: Anti-Bacterial Agents; Child; China; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; RNA, Ribosomal, 23S | 2022 |
[Important rise in antibiotic resistance rates inHelicobacter pyloriin the Netherlands].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Netherlands; Retrospective Studies | 2022 |
A Survey of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests | 2022 |
Recent trends in the antibiotic resistance of Helicobacter pylori in patient with dyspepsia.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Turkey | 2022 |
Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Resistance, Bacterial; Fosfomycin; Furazolidone; Gatifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ornidazole; Rifampin; Tinidazole | 2022 |
Antibiotic resistance patterns of Helicobacter pylori strains isolated from the Tibet Autonomous Region, China.
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Rifampin; Tetracycline; Tibet | 2022 |
Antibiotic resistance patterns of Helicobacter pylori in North Israel - A six-year study.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Rifampin | 2022 |
Determination of the Postexposure Prophylactic Benefit of Oral Azithromycin and Clarithromycin Against Inhalation Anthrax in Cynomolgus Macaques.
Topics: Animals; Anthrax; Anti-Bacterial Agents; Azithromycin; Bacillus anthracis; Clarithromycin; Disease Models, Animal; Levofloxacin; Macaca fascicularis; Respiratory Tract Infections | 2022 |
Alarming antibiotics resistance of Helicobacter pylori from children in Southeast China over 6 years.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracyclines | 2022 |
Transcriptomic and Functional Approaches Unveil the Role of tmRNA in Zinc Acetate Mediated Levofloxacin Sensitivity in Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Transcriptome; Zinc Acetate | 2022 |
Primary Helicobacter pylori resistance to antimicrobials in the Brussels area in 2021.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests | 2023 |
Evaluation of a Molecular Mosprie Assay for Detection of Helicobacter pylori and Resistance to Clarithromycin and Levofloxacin.
Topics: Clarithromycin; Helicobacter pylori; Levofloxacin; Retrospective Studies | 2022 |
Geographic distribution of antibiotic resistance of Helicobacter pylori: A study in Bulgaria.
Topics: Amoxicillin; Anti-Bacterial Agents; Bulgaria; Clarithromycin; COVID-19; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Pandemics | 2023 |
Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; RNA, Ribosomal, 23S; Tetracycline | 2023 |
Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Mutation; RNA, Ribosomal, 23S; Whole Genome Sequencing | 2023 |
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies; Tetracycline | 2023 |
Long-Read- and Short-Read-Based Whole-Genome Sequencing Reveals the Antibiotic Resistance Pattern of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Nucleotides; RNA, Ribosomal, 23S; Tetracycline | 2023 |
Antibiotic susceptibility pattern of Portuguese environmental Legionella isolates.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Doxycycline; Fluoroquinolones; Humans; Legionella; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Microbial Sensitivity Tests; Portugal | 2023 |
Antibiotic resistance characteristics and risk factors analysis of
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Risk Factors; Tetracycline | 2023 |
Antibiotic resistance, heteroresistance, and eradication success of Helicobacter pylori infection in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Tetracycline | 2023 |
Surveillance of Helicobacter pylori resistance over 22 Years (2000-2021) in Northern Spain.
Topics: Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Spain | 2023 |
Antibiotic resistance profile of
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Clarithromycin; Doxycycline; Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2023 |
Antibiotic resistance and heteroresistance in Helicobacter pylori isolates from symptomatic Vietnamese children: A prospective multicenter study.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Prospective Studies; Southeast Asian People; Tetracycline | 2023 |
A comprehensive study of Helicobacter pylori infection: molecular analysis, antibacterial susceptibility, and histopathological examination.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged | 2023 |
Refractory Helicobacter pylori infection in Australia: updated multicentre antimicrobial resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies | 2023 |
Molecular Characterization and Mutational Analysis of Clarithromycin- and Levofloxacin-Resistance Genes in
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; Croatia; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Molecular Docking Simulation; RNA, Ribosomal, 23S | 2023 |
High incidence of antibiotic resistance amongst isolates of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline; United Kingdom | 2023 |
Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial).
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Failure | 2023 |